https://curecurrent.com/trials/comparison-of-venlafaxine-and-fluoxetine-in-the-treatment-of-postmenopausal-women-with-major-depression-120007https://curecurrent.com/trials/a-randomized-double-blind-parallel-group-placebo-controlled-fixed-dose-study-evaluating-the-efficacy-and-safety-of-orvep-120008https://curecurrent.com/trials/glutamatergic-and-gabaergic-mediators-of-antidepressant-response-in-major-depression-120009https://curecurrent.com/trials/a-study-in-the-treatment-of-children-and-adolescents-with-major-depressive-disorder-120010https://curecurrent.com/trials/desvenlafaxine-vs-placebo-treatment-of-chronic-depression-120011https://curecurrent.com/trials/major-depressive-disorder-study-in-adults-120012https://curecurrent.com/trials/memory-flexibility-training-for-depression-120013https://curecurrent.com/trials/the-neurobiology-of-approach-avoidance-training-in-depression-120014https://curecurrent.com/trials/effectiveness-study-of-mirtazapine-combined-with-paroxetine-in-major-depressive-patients-without-early-improvement-120015https://curecurrent.com/trials/deep-brain-magnetic-stimulation-dms-in-the-treatment-of-major-depressive-disorder-120016https://curecurrent.com/trials/out-patient-wake-therapy-light-therapy-and-sleep-phase-advance-for-depression-120017https://curecurrent.com/trials/thinking-healthy-program-peer-delivered-india-thpp-i-120018https://curecurrent.com/trials/gait-depression-and-mind-body-therapy-in-seniors-120019https://curecurrent.com/trials/duloxetine-for-chronic-depression-a-double-blind-study-120020https://curecurrent.com/trials/early-detection-and-prevention-of-mood-disorders-in-children-of-parents-with-bipolar-disorder-120021https://curecurrent.com/trials/ketamine-for-depression-and-suicide-risk-120022https://curecurrent.com/trials/low-intensity-versus-self-guided-internet-delivered-psychotherapy-for-major-depression-120023https://curecurrent.com/trials/evaluation-of-the-safety-of-adjunct-brexpiprazole-in-elderly-patients-with-major-depressive-disorder-and-an-inadequate-r-120024https://curecurrent.com/trials/brexpiprazole-as-adjunctive-treatment-in-patients-with-major-depressive-disorder-with-an-inadequate-response-to-antidepr-120025https://curecurrent.com/trials/prime-cognitive-outcome-following-major-burns-120026https://curecurrent.com/trials/long-term-efficacy-of-metacognitive-training-for-depression-d-mct-120027https://curecurrent.com/trials/first-time-in-human-study-120028https://curecurrent.com/trials/a-6-month-extension-study-to-the-b2061032-study-to-evaluate-the-safety-tolerability-and-efficacy-of-dvs-sr-in-the-treatm-120029https://curecurrent.com/trials/eealy-improvement-predicts-antidepressants-response-in-adults-with-major-depression-disorder-120030https://curecurrent.com/trials/effect-of-ketamine-vs-active-placebo-on-suicidal-ideation-in-depressed-inpatients-with-major-depressive-disorder-or-bipo-120031https://curecurrent.com/trials/pilot-study-of-betahistine-dihydrochloride-in-the-treatment-of-major-depression-with-atypical-features-120032https://curecurrent.com/trials/prevention-of-weight-gain-in-early-psychoses-120033https://curecurrent.com/trials/treating-depression-among-low-income-patients-with-cancer-120034https://curecurrent.com/trials/oral-fluency-and-the-response-to-antidepressant-therapy-in-the-elderly-with-a-unipolar-depressive-episode-120035https://curecurrent.com/trials/frontal-hypoperfusion-effects-on-antidepressant-outcomes-in-late-life-depression-120036https://curecurrent.com/trials/cognitive-training-for-depression-ii-120037https://curecurrent.com/trials/cognitive-training-for-mood-and-anxiety-disorders-120038https://curecurrent.com/trials/a-double-blind-placebo-controlled-study-of-aripiprazole-adjunctive-to-antidepressant-therapy-120039https://curecurrent.com/trials/a-study-of-gw856553x-for-the-treatment-of-depression-120040https://curecurrent.com/trials/creatine-augmentation-treatment-in-major-depressive-disorder-subjects-120041https://curecurrent.com/trials/a-comparison-of-cognitive-behavioral-analysis-system-of-psychotherapy-cbasp-and-system-of-supportive-psychotherapy-sysp-120042https://curecurrent.com/trials/dopamine-receptor-imaging-in-mood-disorders-120043https://curecurrent.com/trials/bone-loss-in-premenopausal-women-with-depression-120044https://curecurrent.com/trials/function-of-catecholamines-in-the-brain-during-depression-120045https://curecurrent.com/trials/brain-regulation-of-emotions-in-people-with-depression-and-anhedonia-120046https://curecurrent.com/trials/evaluating-brain-responses-to-facial-expressions-in-major-depressive-disorder-120047https://curecurrent.com/trials/pet-whole-body-distribution-studies-using-11c-cumi-120048https://curecurrent.com/trials/brain-imaging-in-depression-120049https://curecurrent.com/trials/imaging-serotonin-5ht1a-receptors-in-patients-with-major-depressive-disorder-120050https://curecurrent.com/trials/serotonin-function-during-depression-120051https://curecurrent.com/trials/brain-chemical-receptor-effects-in-patients-with-panic-disorder-and-post-traumatic-stress-disorder-120052https://curecurrent.com/trials/bone-mineral-density-in-women-with-major-depression-120053https://curecurrent.com/trials/heart-disease-risk-factors-in-major-depression-120054https://curecurrent.com/trials/proof-of-concept-trial-of-cerc-501-augmentation-of-antidepressant-therapy-in-treatment-resistant-depression-120055https://curecurrent.com/trials/fmri-study-of-performance-during-a-probabilistic-reversal-learning-task-in-depression-120056https://curecurrent.com/trials/neurocardiac-control-in-major-depression-120057https://curecurrent.com/trials/impact-of-an-eight-week-exercise-intervention-in-treating-major-depressive-disorder-120058https://curecurrent.com/trials/study-of-lurasidone-in-treating-antipsychotic-naive-or-quasi-naive-children-and-adolescents-120059https://curecurrent.com/trials/past-pain-experience-and-perception-of-experimental-pain-120060https://curecurrent.com/trials/life-goals-behavioral-change-to-improve-outcomes-for-veterans-with-serious-mental-illness-120061https://curecurrent.com/trials/a-study-of-mifepristone-vs-placebo-in-the-treatment-of-patients-with-major-depression-with-psychotic-features-120062https://curecurrent.com/trials/treatments-for-depression-drug-versus-psychotherapy-120063https://curecurrent.com/trials/brain-imaging-study-in-menopausal-women-with-and-without-major-depressive-disorder-120064https://curecurrent.com/trials/deep-rtms-for-treatment-resistant-late-life-depression-120065https://curecurrent.com/trials/lethargic-depression-study-120066https://curecurrent.com/trials/sexual-functioning-study-with-antidepressants-120067https://curecurrent.com/trials/mineralocorticoid-receptor-in-the-treatment-of-severe-depression-120068https://curecurrent.com/trials/dialogue-to-empower-traditional-and-faith-healers-to-deliver-mhgap-ig-adapted-psychosocial-interventions-in-kenya-120069https://curecurrent.com/trials/efficacy-of-vortioxetine-on-cognitive-dysfunction-in-patients-with-partial-or-full-remission-of-major-depressive-disorde-120070https://curecurrent.com/trials/lisdexamfetamine-dimesylate-in-residual-symptoms-and-cognitive-impairment-in-major-depressive-disorder-120071https://curecurrent.com/trials/epidural-stimulation-for-resistant-depression-treatment-120072https://curecurrent.com/trials/n-methyl-d-aspartate-antagonist-ketamine-augmentation-of-electroconvulsive-treatment-for-severe-major-depression-120073https://curecurrent.com/trials/use-of-multiple-brain-imaging-modalities-pet-and-mrs-to-identify-metabolic-abnormalities-in-major-depression-120074https://curecurrent.com/trials/neurobiological-bases-of-placebo-response-in-major-depressive-disorder-120075https://curecurrent.com/trials/imaging-the-nucleus-accumbens-in-major-depressed-patients-treated-with-pramipexole-120076https://curecurrent.com/trials/creatine-treatment-for-female-adolescents-with-depression-who-are-non-responders-to-fluoxetine-or-escitalopram-120077https://curecurrent.com/trials/pioglitazone-in-patients-with-mood-disorders-120078https://curecurrent.com/trials/rapid-antidepressant-effects-of-atp-and-phosphocreatine-120079https://curecurrent.com/trials/double-blind-pilot-trial-of-mirtazapine-for-the-treatment-of-co-occurring-ad-mdd-120080https://curecurrent.com/trials/treatment-of-patients-with-major-depressive-disorder-with-mk0869-0869-063-120081https://curecurrent.com/trials/treatment-of-patients-with-major-depressive-disorder-with-mk0869-0869-062-completed-120082https://curecurrent.com/trials/long-term-treatment-of-patients-with-major-depressive-disorder-with-mk0869-0869-065-completed-120083https://curecurrent.com/trials/treatment-of-patients-with-major-depressive-disorder-with-mk0869-0869-068-completed-120084https://curecurrent.com/trials/treatment-of-patients-with-major-depressive-disorder-with-mk0869-0869-073-120085https://curecurrent.com/trials/evaluation-of-pharmacogenetic-testing-in-a-mental-health-population-and-economic-outcomes-120086https://curecurrent.com/trials/pharmacogenetic-testing-on-an-outpatient-population-with-a-depression-diagnosis-120087https://curecurrent.com/trials/pharmacogenetic-testing-in-an-outpatient-population-of-patients-with-depression-120088https://curecurrent.com/trials/a-comparison-of-cognitive-and-dynamic-therapy-for-depression-in-community-settings-120089https://curecurrent.com/trials/open-trial-determining-antidepressant-effects-of-omega-3-supplementation-during-pregnancy-120090https://curecurrent.com/trials/cytokines-pufa-tissue-concentrations-and-treatment-selection-in-antenatal-mdd-120091https://curecurrent.com/trials/depression-and-traumatic-brain-injury-120092https://curecurrent.com/trials/study-of-6-s-5-mthf-among-selective-serotonin-reuptake-inhibitor-resistant-outpatients-with-major-depressive-disorder-120093https://curecurrent.com/trials/treatment-of-young-adults-with-comorbid-aud-mdd-a-pilot-medication-trial-120094https://curecurrent.com/trials/a-clinical-evaluation-of-subcallosal-cingulate-gyrus-deep-brain-stimulation-for-treatment-resistant-depression-120095https://curecurrent.com/trials/stimulant-enhancement-of-well-being-therapy-for-depression-120096https://curecurrent.com/trials/treatment-of-patients-with-major-depressive-disorder-with-mk0869-0869-066-completed-120097https://curecurrent.com/trials/antidepressant-therapy-in-treating-bipolar-type-ii-major-depression-120098https://curecurrent.com/trials/supplemental-transcranial-magnetic-stimulation-tms-vs-standard-medication-monotherapy-for-treating-major-depression-an-e-120099https://curecurrent.com/trials/imaging-biomarkers-for-tms-treatment-of-depression-120100https://curecurrent.com/trials/pet-imaging-of-mglur5-with-drug-challenge-120101https://curecurrent.com/trials/seroquel-alone-versus-seroquel-with-an-ssri-for-depression-with-psychotic-symptoms-120102https://curecurrent.com/trials/transcranial-magnetic-stimulation-in-major-depression-with-eeg-and-near-infrared-spectroscopy-nirs-monitoring-120103https://curecurrent.com/trials/efficacy-and-safety-of-duloxetine-among-individuals-with-depressive-disorder-in-a-12-weeks-trial-120104https://curecurrent.com/trials/measuring-adherence-to-medication-for-depression-and-attention-deficit-hyperactivity-disorder-120105https://curecurrent.com/trials/escitalopram-in-the-treatment-of-adolescents-with-major-depressive-disorder-or-anxiety-disorders-120106https://curecurrent.com/trials/ketamine-infusion-for-treatment-resistant-major-depressive-disorder-120107https://curecurrent.com/trials/ketamine-versus-placebo-for-treatment-resistant-major-depressive-disorder-120108https://curecurrent.com/trials/treatment-of-patients-with-major-depressive-disorder-with-mk0869-0869-061-120109https://curecurrent.com/trials/natural-supplements-for-unipolar-depression-120110https://curecurrent.com/trials/treatment-of-patients-with-major-depressive-disorder-with-mk0869-0869-059-120111https://curecurrent.com/trials/a-study-to-assess-the-effect-and-safety-of-azd6765-in-patients-with-major-depressive-disorder-120112https://curecurrent.com/trials/iloperidone-augmentation-of-ssris-for-patients-with-major-depressive-disorder-with-residual-anger-and-irritability-120113https://curecurrent.com/trials/detecting-depression-and-bipolar-disorder-in-adolescents-using-a-biomarker-panel-120114https://curecurrent.com/trials/decreasing-risk-of-coronary-artery-disease-in-schizophrenia-by-omega-3-fatty-acid-supplementation-120115https://curecurrent.com/trials/cysteamine-therapy-for-major-depressive-disorder-120116https://curecurrent.com/trials/mri-studies-of-emotion-in-depression-120117https://curecurrent.com/trials/brief-multifamily-psychoeducation-for-families-of-patients-with-chronic-major-depression-120118https://curecurrent.com/trials/study-of-quality-of-life-in-freeman-sheldon-syndrome-and-related-conditions-120119https://curecurrent.com/trials/safety-and-effectiveness-of-s-adenosyl-l-methionine-same-for-the-treatment-of-major-depression-120120https://curecurrent.com/trials/treatment-of-psychotic-major-depression-with-mifepristone-120121https://curecurrent.com/trials/treatment-of-nicotine-dependence-and-acute-depression-120122https://curecurrent.com/trials/magnetic-resonance-imaging-study-of-geriatric-depression-120123https://curecurrent.com/trials/feasibility-safety-and-efficacy-of-deep-brain-stimulation-for-depression-120124https://curecurrent.com/trials/the-impact-of-memantine-on-electroconvulsive-therapy-ect-will-it-improve-response-and-protect-against-cognitive-problems-120125https://curecurrent.com/trials/treatment-of-schizoaffective-disorder-using-mifepristone-120126https://curecurrent.com/trials/cognitive-therapy-for-unipolar-depression-efficacy-of-a-dilemma-focused-intervention-120127https://curecurrent.com/trials/a-study-of-dvs-sr-in-treatment-of-children-and-adolescent-outpatients-with-mdd-120128https://curecurrent.com/trials/pilot-ba-study-of-new-ly03005-vs-pristiq-120129https://curecurrent.com/trials/pilot-study-to-evaluate-individualized-choice-of-antidepressants-in-patients-with-cancer-120130https://curecurrent.com/trials/potential-use-of-brain-network-activation-analysis-to-diagnose-major-depression-120131https://curecurrent.com/trials/increasing-use-of-mental-health-services-120132https://curecurrent.com/trials/efficacy-of-vortioxetine-versus-escitalopram-on-cognitive-function-in-patients-with-inadequate-response-to-current-antid-120133https://curecurrent.com/trials/efficacy-of-vortioxetine-on-cognitive-dysfunction-in-working-patients-with-major-depressive-disorder-120134https://curecurrent.com/trials/study-of-nsi-189-for-major-depressive-disorder-120135https://curecurrent.com/trials/low-dose-naltrexone-ldn-for-depression-relapse-and-recurrence-120136https://curecurrent.com/trials/predictors-of-response-to-augmentation-with-ziprasidone-geodon-in-major-depressive-disorder-120137https://curecurrent.com/trials/estimate-the-efficiency-of-the-association-of-an-injection-of-ketamine-and-the-venlafaxine-in-the-severe-major-depressiv-120138https://curecurrent.com/trials/contingency-management-of-alcohol-abuse-in-the-severely-mentally-ill-120139https://curecurrent.com/trials/the-influence-of-the-menstrual-cycle-on-lithium-and-sertraline-blood-levels-120140https://curecurrent.com/trials/ultrabrief-right-unilateral-and-brief-pulse-bitemporal-electroconvulsive-therapy-120141https://curecurrent.com/trials/oral-multiple-dose-study-in-patients-with-major-depressive-disorder-120142https://curecurrent.com/trials/mifepristone-treatment-for-patients-with-non-psychotic-major-depressive-disorder-receiving-bilateral-ect-120143https://curecurrent.com/trials/study-to-evaluate-safety-and-tolerability-of-fk949e-in-patients-with-major-depressive-disorder-120144https://curecurrent.com/trials/study-to-evaluate-safety-and-tolerability-of-fk949e-in-elderly-patients-with-major-depressive-disorder-120145https://curecurrent.com/trials/risks-for-insulin-resistance-and-metabolic-syndrome-between-major-depressive-disorder-mdd-or-mdd-with-psychotic-features-120146https://curecurrent.com/trials/ketamine-for-suicidal-ideation-120147https://curecurrent.com/trials/intranasal-ketamine-in-treatment-resistant-depression-120148https://curecurrent.com/trials/a-6-month-open-label-extension-study-to-the-b2061014-study-to-evaluate-the-safety-tolerability-and-efficacy-of-dvs-sr-in-120149https://curecurrent.com/trials/a-study-of-ly2940094-in-major-depressive-disorder-120150https://curecurrent.com/trials/study-of-the-efficacy-and-safety-of-ly2940094-in-participants-with-major-depressive-disorder-mdd-120151https://curecurrent.com/trials/computerized-cognitive-remediation-for-geriatric-depression-120152https://curecurrent.com/trials/transcranial-electrical-stimulation-tes-for-the-treatment-of-depression-120153https://curecurrent.com/trials/theta-burst-study-ghent-120154https://curecurrent.com/trials/duloxetine-treatment-of-major-depression-and-chronic-low-back-pain-for-older-adults-120155https://curecurrent.com/trials/treatment-resistant-geriatric-depression-in-primary-care-120156https://curecurrent.com/trials/effects-of-tdcs-on-cognitive-control-and-emotion-regulation-in-depressed-patients-120157https://curecurrent.com/trials/randomized-controlled-trial-of-conventional-vs-theta-burst-rtms-120158https://curecurrent.com/trials/controlled-release-paroxetine-in-major-depressive-disorder-double-blind-placebo-controlled-study-120159https://curecurrent.com/trials/a-study-to-investigate-evoked-potentials-as-markers-of-ketamine-induced-cortical-plasticity-in-patients-with-major-depre-120160https://curecurrent.com/trials/the-effect-of-tdcs-in-patients-with-moderate-to-severe-major-depressive-disorder-120161https://curecurrent.com/trials/pioglitazone-for-the-treatment-of-major-depressive-disorder-comorbid-with-metabolic-syndrome-120162https://curecurrent.com/trials/a-pilot-proof-of-concept-cohort-study-of-the-prevalence-of-comorbid-mental-illness-and-substance-abuse-120163https://curecurrent.com/trials/paxil-japanese-post-marketing-paediatric-study-in-depression-double-blind-placebo-controlled-study-120164https://curecurrent.com/trials/open-label-ziprasidone-study-for-psychosis-treatment-in-adolescents-120165https://curecurrent.com/trials/integrated-treatment-for-cocaine-and-mood-disorders-1-120166https://curecurrent.com/trials/preventing-depression-in-methadone-maintenance-patients-receiving-hepatitis-c-treatment-1-120167https://curecurrent.com/trials/treating-major-depression-with-yoga-a-prospective-randomized-controlled-pilot-trial-120168https://curecurrent.com/trials/safety-and-efficacy-study-comparing-ets6103-with-amitriptyline-in-the-treatment-of-major-depressive-disorder-mdd-120169https://curecurrent.com/trials/mental-health-telemetry-for-self-management-in-major-depression-120170https://curecurrent.com/trials/brain-gaba-levels-and-treatment-response-in-major-depressive-disorder-120171https://curecurrent.com/trials/brain-energy-metabolism-in-individuals-with-major-depressive-disorder-receiving-escitalopram-120172https://curecurrent.com/trials/the-experience-of-older-adults-facing-depression-for-the-first-time-in-old-age-120173https://curecurrent.com/trials/a-health-intervention-to-prevent-depression-hepatitis-c-patients-120174https://curecurrent.com/trials/quetiapine-extended-release-xr-treatment-of-major-depressive-disorder-with-comorbid-generalized-anxiety-disorder-120175https://curecurrent.com/trials/evaluating-the-efficacy-of-adjunctive-minocycline-for-the-treatment-of-bipolar-depression-120176https://curecurrent.com/trials/depression-agency-based-collaboration-120177https://curecurrent.com/trials/escitalopram-placebo-and-tdcs-in-depression-a-non-inferiority-trial-120178https://curecurrent.com/trials/effectiveness-and-acceptability-of-moodgym-in-treating-depressive-symptoms-in-chinese-americans-120179https://curecurrent.com/trials/measurement-based-care-for-depression-in-resource-poor-settings-120180https://curecurrent.com/trials/meditation-to-reduce-caregiver-stress-120181https://curecurrent.com/trials/study-of-genetic-differences-in-people-with-depression-120182https://curecurrent.com/trials/the-antidepressant-efficacy-of-the-anticholinergic-scopolamine-120183https://curecurrent.com/trials/efficacy-and-tolerability-of-escitalopram-and-duloxetine-in-outpatients-with-major-depressive-disorder-120184https://curecurrent.com/trials/contingency-management-of-psychostimulant-abuse-in-the-severely-mentally-ill-120185https://curecurrent.com/trials/the-effects-of-vilazodone-on-glutamate-in-the-anterior-cingulate-cortex-in-anxious-unipolar-depressives-120186https://curecurrent.com/trials/dose-finding-study-with-lu-aa24530-in-major-depressive-disorder-120187https://curecurrent.com/trials/study-of-medication-and-placebo-response-in-major-depression-120188https://curecurrent.com/trials/light-therapy-for-bipolar-disorder-efficacy-of-light-therapy-for-bipolar-depression-a-randomized-controlled-trial-120189https://curecurrent.com/trials/artdeco-study-a-study-of-ro4995819-in-patients-with-major-depressive-disorder-and-inadequate-response-to-ongoing-antidep-120190https://curecurrent.com/trials/a-study-of-the-safety-tolerability-and-pharmacokinetics-of-multiple-ascending-dose-basimglurant-in-healthy-subjects-and-120191https://curecurrent.com/trials/marigold-study-a-study-of-ro4917523-versus-placebo-as-adjunctive-therapy-in-patients-with-major-depressive-disorder-and-120192https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-rtms-for-treatment-resistant-depressive-disorder-120193https://curecurrent.com/trials/wake-and-light-therapy-to-in-patients-with-major-depression-efficacy-predictors-and-patient-experiences-120194https://curecurrent.com/trials/neural-genetic-and-peripheral-correlates-of-ssri-pharmaco-response-120195https://curecurrent.com/trials/study-of-the-effects-of-a-new-antidepressant-therapy-in-patients-with-major-depressive-disorder-mdd-120196https://curecurrent.com/trials/task-sharing-counseling-intervention-by-community-health-workers-for-prenatal-depression-in-south-africa-120197https://curecurrent.com/trials/relapse-predicting-model-for-first-episode-depression-120198https://curecurrent.com/trials/dose-ranging-trial-of-creatine-augmentation-for-adolescent-females-with-treatment-resistant-major-depressive-disorder-120199https://curecurrent.com/trials/lexapro-for-the-treatment-of-traumatic-brain-injury-tbi-depression-other-psychiatric-conditions-120200https://curecurrent.com/trials/hyperventilation-combined-with-etomidate-or-ketamine-anesthesia-in-ect-treatment-of-major-depression-120201https://curecurrent.com/trials/cognitive-behavioral-therapy-guided-self-help-versus-individual-therapy-120202https://curecurrent.com/trials/adjunct-interpersonally-focused-psychodynamic-group-psychotherapy-for-residual-depression-symptoms-120203https://curecurrent.com/trials/early-improvement-in-individual-symptoms-and-response-to-antidepressants-in-patients-with-major-depressive-disorder-120204https://curecurrent.com/trials/study-of-brain-response-to-emotional-pictures-using-a-magnetic-resonance-imaging-fmri-while-on-escitalopram-120205https://curecurrent.com/trials/fmri-study-of-brain-response-before-and-after-lithium-treatment-in-people-with-bipolar-disorder-120206https://curecurrent.com/trials/music-therapy-for-major-depressive-disorder-residual-symptoms-120207https://curecurrent.com/trials/strategic-use-of-new-generation-antidepressants-for-depression-120208https://curecurrent.com/trials/study-of-brain-response-to-emotional-pictures-using-a-fmri-while-on-duloxetine-120209https://curecurrent.com/trials/brain-imaging-of-quetiapine-response-in-anxious-depression-120210https://curecurrent.com/trials/electrical-stimulation-in-patients-with-unipolar-major-depression-120211https://curecurrent.com/trials/effectiveness-of-nimodipine-plus-antidepressant-medication-in-treating-vascular-depression-120212https://curecurrent.com/trials/electrical-stimulation-in-patients-with-unipolar-major-depression-120213https://curecurrent.com/trials/a-longitudinal-observational-cohort-study-of-nsi-189-with-out-patients-with-major-depressive-disorder-120214https://curecurrent.com/trials/predictors-of-suicidal-behavior-in-depression-120215https://curecurrent.com/trials/multimodal-assessment-of-neurobiological-markers-for-psychiatric-disorders-120216https://curecurrent.com/trials/vortioxetine-for-the-treatment-of-major-depression-and-co-morbidities-after-traumatic-brain-injury-tbi-120217https://curecurrent.com/trials/depression-study-in-elderly-patients-120218https://curecurrent.com/trials/predictors-of-treatment-response-in-late-onset-major-depressive-disorder-120219https://curecurrent.com/trials/does-vilazodone-help-with-antidepressant-associated-sexual-dysfunction-120220https://curecurrent.com/trials/vortioxetine-in-patients-with-major-depressive-disorder-and-coronary-artery-disease-120221https://curecurrent.com/trials/vortioxetine-versus-placebo-in-major-depressive-disorder-comorbid-with-social-anxiety-disorder-120222https://curecurrent.com/trials/study-of-transcranial-direct-current-stimulation-tdcs-as-add-on-treatment-for-resistant-major-depression-120223https://curecurrent.com/trials/psychotherapeutic-text-messaging-for-depression-pilot-study-120224https://curecurrent.com/trials/kappa-opioid-receptor-imaging-in-depression-kor-depression-120225https://curecurrent.com/trials/early-detection-and-intervention-for-the-prevention-of-psychosis-120226https://curecurrent.com/trials/creatine-augmentation-in-veterans-with-ssri-resistant-major-depression-120227https://curecurrent.com/trials/prj2215-assessment-of-buproprion-misuse-abuse-2004-2011-120228https://curecurrent.com/trials/acute-affective-organic-disorders-120229https://curecurrent.com/trials/safety-study-of-ziprasidone-geodon-for-the-depressive-mixed-state-120230https://curecurrent.com/trials/predictive-nature-of-total-cholesterol-threshold-possible-link-to-suicidal-behavior-120231https://curecurrent.com/trials/a-clinical-trial-for-the-treatment-of-depression-with-repetitive-transcranial-magnetic-stimulation-rtms-120232https://curecurrent.com/trials/major-depressive-disorder-mdd-with-mixed-features-flexible-dose-120233https://curecurrent.com/trials/a-double-blind-randomized-placebo-controlled-study-of-the-efficacy-safety-and-of-quetiapine-fumarate-seroquel-as-potenti-120234https://curecurrent.com/trials/a-study-to-evaluate-the-impact-of-escitalopram-on-quality-of-life-and-social-functionality-in-patients-with-major-depres-120235https://curecurrent.com/trials/brexpiprazole-opc-34712-trial-in-the-treatment-of-adults-with-major-depressive-disorder-and-irritability-120236https://curecurrent.com/trials/neuroinflammation-serotonin-impulsivity-and-suicide-120237https://curecurrent.com/trials/phenotype-depression-study-120238https://curecurrent.com/trials/duloxetine-for-the-treatment-of-postpartum-depression-120239https://curecurrent.com/trials/maintaining-mechanisms-of-chronic-depression-and-their-changeability-120240https://curecurrent.com/trials/the-impact-of-psychological-interventions-on-psychometric-and-immunological-measures-in-patients-with-major-depression-120241https://curecurrent.com/trials/an-open-label-study-of-clinical-utility-and-patient-outcomes-of-the-genecept-assay-120242https://curecurrent.com/trials/efficacy-and-safety-of-cranial-electrical-stimulation-ces-for-major-depressive-disorder-mdd-120243https://curecurrent.com/trials/omega-3-fatty-acids-as-adjunct-treatment-for-major-depressive-disorder-120244https://curecurrent.com/trials/abilify-as-an-adjunctive-treatment-for-refractory-depression-120245https://curecurrent.com/trials/an-eight-week-study-of-saredutant-and-paroxetine-as-combination-treatment-for-major-depressive-disorder-120246https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-armodafinil-treatment-150-mg-day-as-adjunctive-therapy-in-adults-with-major-120247https://curecurrent.com/trials/trial-of-transcranial-direct-current-stimulation-tdcs-using-alternative-electrode-montages-120248https://curecurrent.com/trials/an-eight-week-study-of-saredutant-and-escitalopram-as-combination-treatment-for-major-depressive-disorder-120249https://curecurrent.com/trials/an-eight-week-study-evaluating-the-efficacy-of-a-100mg-dose-of-saredutant-once-daily-in-elderly-patients-with-major-depr-120250https://curecurrent.com/trials/objective-diagnostic-markers-and-personalized-intervention-in-mdd-patients-120251https://curecurrent.com/trials/low-field-magnetic-stimulation-in-mood-disorders-using-the-lfms-device-120252https://curecurrent.com/trials/a-24-52-week-study-to-evaluate-the-long-term-efficacy-and-safety-of-saredutant-in-patients-with-depression-magenta-120253https://curecurrent.com/trials/cognitive-dysfunction-and-glucagon-like-peptide-1-agonists-120254https://curecurrent.com/trials/family-psychoeducation-for-major-depressive-disorder-120255https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-armodafinil-treatment-as-adjunctive-therapy-in-adults-with-major-depression-120256https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-armodafinil-treatment-as-adjunctive-therapy-in-adults-with-major-depressi-120257https://curecurrent.com/trials/study-of-repetitive-transcranial-magnetic-stimulation-rtms-in-depressed-teens-120258https://curecurrent.com/trials/lepr-polymorphism-weight-gain-by-mirtazapine-in-late-life-depression-120259https://curecurrent.com/trials/combining-emotion-regulation-and-mindfulness-skills-for-preventing-depression-relapse-120260https://curecurrent.com/trials/prevention-of-adolescent-major-depression-120261https://curecurrent.com/trials/trial-of-a-positive-psychology-intervention-in-major-depressive-disorder-120262https://curecurrent.com/trials/using-mental-health-telemetry-to-predict-relapse-and-re-hospitalization-in-mood-disorders-120263https://curecurrent.com/trials/low-field-magnetic-stimulation-lfms-in-mood-disorders-6-treatments-120264https://curecurrent.com/trials/major-depressive-disorder-with-mixed-features-extension-120265https://curecurrent.com/trials/screening-of-adolescent-mental-suffering-120266https://curecurrent.com/trials/study-using-pregnenolone-to-treat-bipolar-depression-120267https://curecurrent.com/trials/brexpiprazole-opc-34712-as-an-adjunctive-treatment-in-adults-with-major-depressive-disorder-and-anxiety-symptoms-120268https://curecurrent.com/trials/b-vitamins-in-mthfr-positive-patients-with-major-depression-a-post-hoc-analysis-of-findings-120269https://curecurrent.com/trials/brexpiprazole-opc-34712-as-an-adjunctive-treatment-in-active-adults-18-to-35-years-old-with-major-depressive-disorder-wh-120270https://curecurrent.com/trials/safety-and-efficacy-of-evt-101-in-treatment-resistant-depression-120271https://curecurrent.com/trials/brief-behavioral-activation-treatment-for-depression-with-inpatients-120272https://curecurrent.com/trials/add-on-study-of-msi-195-s-adenosyl-l-methionine-same-for-patients-with-major-depressive-disorder-mdd-120273https://curecurrent.com/trials/aripiprazole-and-resistant-postpartum-depression-120274https://curecurrent.com/trials/bringing-what-works-to-youth-in-corrections-a-trauma-intervention-120275https://curecurrent.com/trials/efficacy-and-safety-of-glyx-13-in-subjects-with-inadequate-partial-response-to-antidepressants-120276https://curecurrent.com/trials/study-of-intravenous-nrx-1074-in-patients-with-major-depressive-disorder-120277https://curecurrent.com/trials/schema-focused-therapy-for-chronic-depression-120278https://curecurrent.com/trials/study-of-brexpiprazole-as-adjunctive-treatment-of-irritability-in-patients-with-major-depressive-disorder-and-an-inadequ-120279https://curecurrent.com/trials/health-care-management-for-the-elderly-in-community-through-screening-120280https://curecurrent.com/trials/reducing-internalized-stigma-in-people-with-serious-mental-illness-120281https://curecurrent.com/trials/hpa-axis-activity-due-to-early-traumatic-stress-and-metabolic-symptoms-120282https://curecurrent.com/trials/cbt-vs-rtw-intervention-for-patients-with-common-subclinical-mental-illness-in-primary-care-120283https://curecurrent.com/trials/cbt-versus-a-return-to-work-intervention-for-patients-with-common-mental-illness-in-primary-care-120284https://curecurrent.com/trials/paliperidone-and-lithium-in-the-treatment-of-suicidality-treatment-indication-and-epigenetic-regulation-120285https://curecurrent.com/trials/spirituality-teaching-program-for-depressed-adults-120286https://curecurrent.com/trials/study-of-the-safety-and-efficacy-of-opc-34712-as-adjunctive-therapy-in-the-treatment-of-patients-with-major-depressive-d-120287https://curecurrent.com/trials/rumination-focused-cognitive-behavioral-therapy-for-major-depression-and-recurrent-depression-120288https://curecurrent.com/trials/the-development-of-skin-adhesive-patches-for-the-monitoring-and-prediction-of-mental-disorders-120289https://curecurrent.com/trials/study-of-safety-tolerability-and-pharmacokinetics-of-nrx-1074-in-normal-healthy-volunteers-120290https://curecurrent.com/trials/rechargeable-neurostimulators-in-deep-brain-stimulation-for-psychiatric-disorders-120291https://curecurrent.com/trials/using-a-text-message-system-to-engage-depressed-adolescents-in-cognitive-behavioral-therapy-homework-120292https://curecurrent.com/trials/psychosis-early-detection-intervention-and-prevention-120293https://curecurrent.com/trials/a-study-to-investigate-the-effect-of-jnj-42847922-on-polysomnography-measures-in-patients-with-major-depressive-disorder-120294https://curecurrent.com/trials/phase-1-study-to-assess-the-safety-tolerability-of-brexpiprazole-as-adjunctive-therapy-in-elderly-subjects-with-major-de-120295https://curecurrent.com/trials/neurorestorative-effects-of-electroconvulsive-therapy-ect-in-patients-with-severe-late-life-depression-120296https://curecurrent.com/trials/open-label-placebo-for-the-treatment-of-depression-120297https://curecurrent.com/trials/antidepressants-to-promote-recovery-of-cardiac-patients-suffering-from-depression-120298https://curecurrent.com/trials/neuropsychobiological-correlates-of-sex-steroid-hormone-manipulation-in-healthy-women-a-risk-model-for-depression-120299https://curecurrent.com/trials/life-goals-collaborative-care-to-improve-health-outcomes-in-mental-disorders-120300https://curecurrent.com/trials/functional-neuroanatomy-and-regional-metabolism-before-and-after-treatment-with-duloxetine-120301https://curecurrent.com/trials/transcranial-direct-current-stimulation-as-an-augmenting-intervention-for-major-depression-120302https://curecurrent.com/trials/desvenlafaxine-succinate-pristiq-postmarketing-surveillance-study-among-filipino-patients-120303https://curecurrent.com/trials/pharmacotherapy-in-depression-with-panic-spectrum-120304https://curecurrent.com/trials/effectiveness-of-interpersonal-psychotherapy-ipt-for-men-and-women-prisoners-with-major-depression-120305https://curecurrent.com/trials/group-interpersonal-psychotherapy-for-treatment-of-major-depressive-disorder-following-perinatal-loss-120306https://curecurrent.com/trials/impact-of-immune-challenge-on-triple-network-connectivity-in-humans-120307https://curecurrent.com/trials/study-of-genes-in-relation-to-seasonal-affective-disorder-and-major-depressive-disorder-120308https://curecurrent.com/trials/sequential-treatment-of-pediatric-mdd-to-increase-remission-and-prevent-relapse-120309https://curecurrent.com/trials/retrospective-analysis-of-outcomes-with-a-pharmacogenomic-algorithm-120310https://curecurrent.com/trials/study-of-the-safety-and-efficacy-of-two-fixed-doses-of-opc-34712-as-adjunctive-therapy-in-the-treatment-of-adults-with-m-120311https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-rtms-in-the-treatment-of-depression-120312https://curecurrent.com/trials/trazodone-once-a-day-in-major-depression-disorder-120313https://curecurrent.com/trials/brexpiprazole-as-adjunctive-therapy-with-major-depressive-disorder-and-an-inadequate-response-to-previous-adjunctive-the-120314https://curecurrent.com/trials/treatment-resistant-depression-registry-120315https://curecurrent.com/trials/cognitive-control-training-for-remitted-depressed-patients-120316https://curecurrent.com/trials/an-investigation-of-the-sleep-architecture-and-consequent-cognitive-changes-in-olanzapine-treated-depressed-patients-120317https://curecurrent.com/trials/effect-of-quetiapine-on-sleep-architecture-in-bipolar-depression-and-major-depressive-disorder-120318https://curecurrent.com/trials/does-sleep-quality-change-after-switch-from-wellbutrin-sr-to-wellbutrin-xl-in-patients-with-major-depressive-disorder-120319https://curecurrent.com/trials/pharmacokinetics-pharmacodynamic-study-of-ht-2157-in-healthy-subjects-and-in-patients-with-major-depressive-disorder-120320https://curecurrent.com/trials/mobile-apps-for-the-treatment-of-depression-120321https://curecurrent.com/trials/integral-assessment-in-unipolar-depression-120322https://curecurrent.com/trials/multicomponent-yoga-intervention-for-major-depressive-disorder-120323https://curecurrent.com/trials/study-of-depression-ketamine-brain-function-120324https://curecurrent.com/trials/a-positron-emission-topographic-pet-study-on-depression-patient-with-electroacupuncture-120325https://curecurrent.com/trials/a-paroxetine-and-placebo-controlled-study-of-50-mg-day-and-100-mg-day-of-eb-1010-among-outpatients-with-major-depressive-120326https://curecurrent.com/trials/pharmacogenetic-directed-treatment-for-major-depression-120327https://curecurrent.com/trials/anti-inflammatory-to-address-mood-and-endothelial-dysfunction-inflamed-120328https://curecurrent.com/trials/open-pilot-trial-of-tes-for-depression-120329https://curecurrent.com/trials/investigating-tdcs-as-a-treatment-for-unipolar-and-bipolar-depression-120330https://curecurrent.com/trials/a-study-to-determine-the-efficacy-and-safety-of-2-doses-of-org-34517-as-adjunctive-therapy-in-subjects-with-psychotic-ma-120331https://curecurrent.com/trials/phospholipid-hypothesis-of-depression-from-molecular-biology-neuroimaging-to-behaviour-120332https://curecurrent.com/trials/study-of-the-safety-and-efficacy-of-fixed-dose-opc-34712-as-adjunctive-therapy-in-the-treatment-of-adults-with-major-dep-120333https://curecurrent.com/trials/a-study-of-fluoxetine-in-major-depressive-disorder-mdd-long-term-dosing-120334https://curecurrent.com/trials/physical-exercise-as-an-adjunct-treatment-for-depression-120335https://curecurrent.com/trials/urinary-metabonomics-of-two-major-patterns-of-nafld-120336https://curecurrent.com/trials/partnership-in-medication-management-pimm-in-patients-with-mood-disorders-120337https://curecurrent.com/trials/thyroid-medication-and-antidepressants-for-treating-major-depression-120338https://curecurrent.com/trials/neurostar-tms-therapy-system-utilization-and-outcomes-120339https://curecurrent.com/trials/can-genetics-predict-treatment-response-to-a-computerized-self-help-program-for-depression-120340https://curecurrent.com/trials/study-of-safety-tolerability-of-opc-34712-as-adjunctive-therapy-in-treatment-of-adult-patients-with-major-depressive-dis-120341https://curecurrent.com/trials/study-of-the-safety-and-efficacy-of-opc-34712-as-adjunctive-therapy-in-the-treatment-of-adults-with-major-depressive-dis-120342https://curecurrent.com/trials/synchronized-transcranial-magnetic-stimulation-stms-in-major-depressive-disorder-120343https://curecurrent.com/trials/multiple-ascending-dose-study-in-healthy-subjects-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-ly03005-120344https://curecurrent.com/trials/efficacy-of-electronic-cognitive-behavioral-therapy-application-to-treat-major-depressive-disorder-120345https://curecurrent.com/trials/efficacy-and-safety-of-fixed-doses-of-bms-820836-in-the-treatment-of-patients-with-treatment-resistant-major-depression-120346https://curecurrent.com/trials/long-term-safety-and-tolerability-of-bms-820836-in-the-treatment-of-patients-with-treatment-resistant-major-depression-120347https://curecurrent.com/trials/efficacy-and-safety-of-flexibly-dosed-bms-820836-in-the-treatment-of-patients-with-treatment-resistant-major-depression-120348https://curecurrent.com/trials/complex-dynamic-systems-in-mood-disorders-120349https://curecurrent.com/trials/multicenter-comparative-study-of-the-activity-of-the-medial-prefrontal-cortex-in-vulnerability-to-depression-120350https://curecurrent.com/trials/feasibility-and-tolerability-of-adjunct-chronotherapy-in-depressed-inpatients-120351https://curecurrent.com/trials/antidepressant-plus-asenapine-versus-antidepressant-plus-placebo-for-depression-120352https://curecurrent.com/trials/tns-for-treating-major-depressive-disorder-in-the-elderly-120353https://curecurrent.com/trials/tvns-for-depression-120354https://curecurrent.com/trials/improving-depression-outcome-by-enhancing-memory-for-cognitive-therapy-120355https://curecurrent.com/trials/trial-of-transcranial-direct-current-stimulation-tdcs-for-depression-120356https://curecurrent.com/trials/jump-step-a-participatory-approach-to-physical-activity-mental-wellness-120357https://curecurrent.com/trials/effect-of-antidepressants-on-the-treatment-for-korean-major-depressive-disorder-patients-120358https://curecurrent.com/trials/neurocognitive-enhancement-in-major-depressive-disorder-120359https://curecurrent.com/trials/continuation-electroconvulsive-therapy-c-ect-for-relapse-prevention-in-major-depression-120360https://curecurrent.com/trials/pulsating-electromagnetive-treatment-pemf-at-treatment-resistant-depression-120361https://curecurrent.com/trials/desipramine-for-improving-cellular-signaling-and-decreasing-symptoms-of-major-depression-120362https://curecurrent.com/trials/ostrobothnia-depression-study-ods-a-naturalistic-follow-up-study-on-depression-and-related-substance-use-disorders-120363https://curecurrent.com/trials/assessing-the-impact-of-self-directed-care-within-a-medicaid-funded-environment-on-participation-and-community-living-120364https://curecurrent.com/trials/the-brain-on-whole-body-hyperthermia-a-neuroimaging-study-120365https://curecurrent.com/trials/whole-body-hyperthermia-and-major-depression-mdd-120366https://curecurrent.com/trials/effects-of-seroquel-xr-on-sleep-architecture-in-patients-with-major-depressive-disorder-120367https://curecurrent.com/trials/chicago-urban-resiliency-building-curb-120368https://curecurrent.com/trials/family-based-treatment-of-depressed-adolescents-120369https://curecurrent.com/trials/prevalence-and-risk-factors-in-unipolar-depression-patients-without-remission-after-one-antidepressant-trial-120370https://curecurrent.com/trials/e-mental-health-adolescent-depression-program-leap-120371https://curecurrent.com/trials/enhancing-psychotherapy-for-mood-disorders-with-whole-body-hyperthermia-120372https://curecurrent.com/trials/blame-rebalance-fmri-feedback-proof-of-concept-120373https://curecurrent.com/trials/depression-epinephrine-and-platelet-function-120374https://curecurrent.com/trials/deep-brain-stimulation-in-treatment-refractory-depression-120375https://curecurrent.com/trials/modeling-and-predicting-real-world-behavior-using-mobile-sensor-data-on-patients-with-major-depressive-disorder-120376https://curecurrent.com/trials/electroconvulsive-therapy-ect-for-elderly-patients-with-major-depression-120377https://curecurrent.com/trials/a-prospective-epidemiological-research-on-functioning-outcomes-related-to-major-depressive-disorder-120378https://curecurrent.com/trials/the-effect-of-minocycline-on-relapse-after-successful-intravenous-ketamine-minocycline-induced-symptoms-response-in-subj-120379https://curecurrent.com/trials/the-effect-of-patient-and-investigator-expectation-on-the-efficacy-of-escitalopram-in-the-treatment-depression-120380https://curecurrent.com/trials/melatonin-agonist-effects-of-tasimelteon-versus-placebo-in-patients-with-major-depressive-disorder-120381https://curecurrent.com/trials/a-study-of-jnj-40411813-as-supplementary-treatment-to-an-antidepressant-in-adults-with-depression-and-anxiety-symptoms-120382https://curecurrent.com/trials/lamotrigine-alone-compared-to-lamotrigine-plus-antidepressant-for-the-treatment-of-bipolar-ii-depression-120383https://curecurrent.com/trials/clinical-trials-of-three-non-drug-treatments-for-winter-depression-sad-120384https://curecurrent.com/trials/sertraline-vs-venlafaxine-xr-120385https://curecurrent.com/trials/the-effectiveness-of-sertraline-in-patients-who-have-had-inadequate-response-to-escitalopram-120386https://curecurrent.com/trials/risperidone-vs-bupropion-er-augmentation-of-ssris-in-treatment-resistant-depression-120387https://curecurrent.com/trials/can-additional-drug-therapy-accelerate-response-time-to-antidepressants-120388https://curecurrent.com/trials/t-boom-teens-building-options-and-opportunities-for-moms-120389https://curecurrent.com/trials/neuronal-responses-to-social-feedback-in-major-depressive-disorder-120390https://curecurrent.com/trials/neural-predictors-and-longitudinal-neural-correlates-of-deep-transcranial-magnetic-stimulation-for-treating-major-depres-120391https://curecurrent.com/trials/deep-brain-stimulation-of-nucleus-accumbens-for-chronic-and-resistant-major-depressive-disorder-120392https://curecurrent.com/trials/escitalopram-pindolol-onset-of-action-120393https://curecurrent.com/trials/effectiveness-of-internet-based-depression-treatment-evident-in-severe-depression-120394https://curecurrent.com/trials/safety-and-efficacy-of-vilazodone-in-major-depressive-disorder-120395https://curecurrent.com/trials/a-study-of-fluoxetine-in-major-depressive-disorder-mdd-short-term-dosing-120396https://curecurrent.com/trials/tns-for-major-depressive-disorder-a-phase-ii-randomized-controlled-trial-120397https://curecurrent.com/trials/functional-brain-imaging-study-of-response-to-repetitive-tms-rtms-treatment-of-major-depression-120398https://curecurrent.com/trials/study-of-bupropion-sr-323u66-in-patients-with-major-depressive-disorder-in-japan-120399https://curecurrent.com/trials/study-of-technology-assisted-treatment-of-adolescent-depression-120400https://curecurrent.com/trials/therapeutic-effectiveness-of-exercise-associated-to-the-pharmacotherapy-in-major-depression-120401https://curecurrent.com/trials/internet-based-depression-screening-for-college-students-120402https://curecurrent.com/trials/neurochemical-metabonomics-and-neuroimaging-characterization-of-tcm-diagnostic-subtypes-of-major-depression-disorder-120403https://curecurrent.com/trials/the-effectiveness-of-fmpo-in-improving-the-quality-of-care-for-persons-with-severe-mental-illness-120404https://curecurrent.com/trials/antidepressant-safety-in-kids-study-120405https://curecurrent.com/trials/switching-from-generic-selective-serotonin-reuptake-inhibitors-ssris-and-selective-serotonin-and-norepinephrine-reuptake-120406https://curecurrent.com/trials/an-8-week-study-of-depression-in-adults-diagnosed-with-major-depressive-disorder-120407https://curecurrent.com/trials/study-of-gw679769-in-major-depressive-disorder-120408https://curecurrent.com/trials/an-8-week-study-of-adults-diagnosed-with-major-depressive-disorder-120409https://curecurrent.com/trials/somatosensory-processing-in-depression-120410https://curecurrent.com/trials/the-effect-of-fish-oil-in-major-depressive-disorder-120411https://curecurrent.com/trials/acamprosate-in-alcoholics-with-comorbid-anxiety-or-depression-120412https://curecurrent.com/trials/neurocognition-and-work-productivity-in-major-depressive-disorder-mdd-120413https://curecurrent.com/trials/adaptation-of-dialectical-behavior-therapy-skills-groups-for-individuals-with-suicidal-ideation-and-depression-120414https://curecurrent.com/trials/evaluation-study-of-tides-depression-care-quality-improvement-intervention-120415https://curecurrent.com/trials/open-label-pilot-study-to-examine-the-value-of-substituting-quetiapine-for-benzodiazepines-120416https://curecurrent.com/trials/effect-of-physical-activity-on-depressive-symptoms-with-a-5-month-follow-up-120417https://curecurrent.com/trials/the-early-medication-change-emc-trial-120418https://curecurrent.com/trials/comparison-of-yuxintine-with-placebo-in-treatment-of-mdd-120419https://curecurrent.com/trials/an-open-label-study-of-the-genecept-assay-in-treatment-resistant-depression-120420https://curecurrent.com/trials/evaluation-of-the-deep-tms-h-coil-in-the-treatment-of-major-depression-augmentation-of-antidepressant-medication-120421https://curecurrent.com/trials/sensitivity-of-short-and-long-allele-carriers-of-the-5-httlpr-to-environmental-threat-post-hydrocortisone-administration-120422https://curecurrent.com/trials/early-integrated-intervention-in-severe-affective-disorders-120423https://curecurrent.com/trials/cognitive-behavioral-treatments-for-depression-in-chronic-illness-120424https://curecurrent.com/trials/antidepressant-adherence-via-ad-ivr-120425https://curecurrent.com/trials/maintenance-rtms-for-treatment-resistant-depression-trd-a-one-year-double-blind-controlled-study-120426https://curecurrent.com/trials/the-effect-of-traumatic-childbirth-on-the-incidence-of-ptsd-and-other-major-postpartum-psychopathology-120427https://curecurrent.com/trials/effect-of-intranasal-insulin-on-depressive-symptoms-in-major-depressive-disorder-120428https://curecurrent.com/trials/treatment-of-patients-with-major-depressive-disorder-with-mk0869-0869-060-completed-120429https://curecurrent.com/trials/efficacy-of-lu-aa21004-on-cognitive-dysfunction-in-major-depressive-disorder-120430https://curecurrent.com/trials/functional-outcome-in-postpartum-depression-in-women-treated-with-desvenlafaxine-120431https://curecurrent.com/trials/magnetic-seizure-therapy-mst-for-severe-mood-disorder-120432https://curecurrent.com/trials/auricular-acupuncture-vs-progressive-muscle-relaxation-in-patients-with-anxiety-disorders-or-major-depressive-disorder-120433https://curecurrent.com/trials/evaluation-of-the-in-shape-fitness-intervention-for-adults-with-serious-mental-illness-120434https://curecurrent.com/trials/prediction-of-antidepressant-treatment-response-using-machine-learning-classification-analysis-120435https://curecurrent.com/trials/peer-support-for-severe-mental-disorders-120436https://curecurrent.com/trials/project-to-improve-symptoms-and-mood-in-people-with-spinal-cord-injury-120437https://curecurrent.com/trials/a-duloxetine-dosing-strategy-study-in-korean-patients-with-major-depressive-disorder-120438https://curecurrent.com/trials/safety-of-org-34517-900-mg-in-patients-who-received-org-34517-in-a-previous-trial-study-28133-p05842-120439https://curecurrent.com/trials/study-of-placebo-without-deception-versus-standard-antidepressant-for-major-depressive-disorder-120440https://curecurrent.com/trials/a-waitlist-controlled-trial-of-the-unified-protocol-for-the-treatment-of-emotional-disorders-in-adolescents-120441https://curecurrent.com/trials/comparison-of-three-electroconvulsive-therapy-ect-techniques-for-the-treatment-of-major-depression-120442https://curecurrent.com/trials/a-finnish-community-randomized-psychotherapy-effectiveness-study-for-major-depression-120443https://curecurrent.com/trials/relapse-prevention-with-escitalopram-or-nortriptyline-following-electro-convulsive-treatment-duag-7-120444https://curecurrent.com/trials/the-effects-and-mechanisms-of-mindfulness-based-cognitive-therapy-mbct-on-depressive-symptoms-and-depression-relapse-120445https://curecurrent.com/trials/pilot-study-of-behavioral-activation-for-prolonged-grief-120446https://curecurrent.com/trials/effects-of-early-abuse-on-adult-intimate-relationships-120447https://curecurrent.com/trials/practicing-alternative-techniques-to-heal-from-depression-the-path-d-study-120448https://curecurrent.com/trials/relapse-prevention-study-of-desvenlafaxine-succinate-sustained-release-in-outpatients-with-major-depressive-disorder-120449https://curecurrent.com/trials/primary-prevention-of-major-depression-based-on-the-level-and-profile-of-risk-of-primary-care-attenders-cluster-controll-120450https://curecurrent.com/trials/retrospective-observational-study-diana-study-120451https://curecurrent.com/trials/efficacy-study-of-vortioxetine-lu-aa21004-for-treatment-of-major-depressive-disorder-120452https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-study-of-ly03005-120453https://curecurrent.com/trials/adjunctive-pregnenolone-in-post-traumatic-stress-disorder-ptsd-and-depression-in-operations-enduring-freedom-and-iraqi-f-120454https://curecurrent.com/trials/randomized-controlled-and-open-label-study-of-buspirone-add-on-treatment-in-patients-with-major-depression-disorder-120455https://curecurrent.com/trials/this-is-a-study-to-determine-the-antidepressant-effects-of-azd6765-120456https://curecurrent.com/trials/study-to-assess-the-distribution-metabolism-and-excretion-of-14c-azd6765-after-a-single-dose-intravenous-administration-120457https://curecurrent.com/trials/study-where-pharmaco-magnetic-resonance-imaging-mri-effects-of-azd6765-will-be-compared-to-placebo-in-depressive-male-an-120458https://curecurrent.com/trials/study-of-vortioxetine-lu-aa21004-in-major-depressive-disorder-in-asian-countries-120459https://curecurrent.com/trials/a-study-of-the-neurobiology-of-depression-120460https://curecurrent.com/trials/a-study-of-new-medicine-gsk-372475-for-the-treatment-of-depression-120461https://curecurrent.com/trials/efficacy-study-of-korean-red-ginseng-to-treat-depression-120462https://curecurrent.com/trials/homeopathic-treatment-for-depression-in-peri-and-postmenopausal-women-120463https://curecurrent.com/trials/vortioxetine-lu-aa21004-10-and-20-mg-for-treatment-of-major-depressive-disorder-with-sexual-dysfunction-120464https://curecurrent.com/trials/accelerated-rtms-for-treatment-resistant-major-depression-120465https://curecurrent.com/trials/role-of-inflammation-factors-and-insulin-resistance-in-major-depressive-disorder-120466https://curecurrent.com/trials/magnetic-resonance-imaging-study-of-cognitive-behavior-therapy-for-major-depressive-disorder-120467https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-rtms-in-the-treatment-of-panic-disorder-with-comorbid-major-depression-120468https://curecurrent.com/trials/cost-effectiveness-of-a-non-pharmacological-treatment-active-monitoring-vs-a-pharmacological-treatment-for-major-depress-120469https://curecurrent.com/trials/pet-biomarkers-in-treatment-resistant-depression-120470https://curecurrent.com/trials/enhanced-collaborative-depression-treatment-in-primary-care-the-respect-d-e-trial-120471https://curecurrent.com/trials/optimizing-antidepressant-treatment-by-genotype-dependent-adjustment-of-medication-according-to-the-abcb1-gene-120472https://curecurrent.com/trials/treatment-of-major-depressive-disorder-post-stroke-with-transcranial-direct-current-stimulation-120473https://curecurrent.com/trials/study-to-evaluate-the-efficacy-of-duloxetine-in-outpatients-with-major-depressive-disorder-and-pain-120474https://curecurrent.com/trials/a-stepped-care-model-of-adolescent-depression-treatment-in-primary-care-120475https://curecurrent.com/trials/a-clinical-trial-of-ipt-a-to-prevent-suicide-in-depressed-adolescents-with-suicidal-behavior-120476https://curecurrent.com/trials/ketamine-infusions-for-major-depression-disorder-120477https://curecurrent.com/trials/depression-treatment-in-general-medical-settings-120478https://curecurrent.com/trials/neuromarkers-identification-in-major-depressive-disorder-based-on-monitoring-measures-120479https://curecurrent.com/trials/quetiapine-in-co-morbid-depressive-and-anxiety-disorders-120480https://curecurrent.com/trials/ziprasidone-vs-sertraline-haloperidol-in-psychotic-depression-120481https://curecurrent.com/trials/comparing-the-effects-of-four-types-of-electroconvulsive-therapy-on-mood-and-thinking-in-people-with-depression-120482https://curecurrent.com/trials/epigenetic-regulation-of-bdnf-in-major-depression-120483https://curecurrent.com/trials/cognitive-bias-modification-cbm-via-imagery-and-internet-cognitive-behavioural-therapy-icbt-for-depression-120484https://curecurrent.com/trials/effectiveness-of-repetitive-transcranial-magnetic-stimulation-in-depressed-patients-120485https://curecurrent.com/trials/safety-and-efficacy-of-vilazodone-in-major-depressive-disorder-120486https://curecurrent.com/trials/safety-and-efficacy-of-levomilnacipran-er-f2695-sr-in-adults-with-fatigue-associated-with-major-depressive-disorder-120487https://curecurrent.com/trials/the-effects-of-wellbutrin-bupropion-on-residual-and-cognitive-symptoms-in-ssri-treated-depression-120488https://curecurrent.com/trials/a-safety-and-effectiveness-study-of-jnj-18038683-in-patients-with-moderate-to-severe-depression-120489https://curecurrent.com/trials/efficacy-study-of-vortioxetine-on-cognitive-dysfunction-in-adult-patients-with-major-depressive-disorder-120490https://curecurrent.com/trials/effects-of-duloxetine-vs-escitalopram-on-heart-rate-variability-in-depression-120491https://curecurrent.com/trials/safety-and-effectiveness-of-omega-3-fatty-acids-epa-versus-dha-for-the-treatment-of-major-depression-120492https://curecurrent.com/trials/the-measurement-based-care-in-patients-with-depressive-disorder-a-randomized-controlled-trial-120493https://curecurrent.com/trials/efficacy-and-safety-of-paroxetine-controlled-release-for-major-depressive-disorder-in-irritable-bowel-syndrome-patients-120494https://curecurrent.com/trials/evaluation-of-a-natural-experiment-to-improve-statewide-depression-care-in-minnesota-mn-120495https://curecurrent.com/trials/ziprasidone-augmentation-of-ssris-for-patients-with-major-depressive-disorder-mdd-that-do-not-sufficiently-respond-to-tr-120496https://curecurrent.com/trials/a-12-week-placebo-controlled-trial-of-ziprasidone-as-monotherapy-for-major-depressive-disorder-120497https://curecurrent.com/trials/biomarkers-of-antidepressant-treatment-in-adolescents-with-major-depression-the-adolescents-mdd-study-120498https://curecurrent.com/trials/sertraline-for-preventing-post-stroke-depression-and-improving-rehabilitation-outcomes-120499https://curecurrent.com/trials/online-self-help-for-depressed-patients-awaiting-psychotherapy-120500https://curecurrent.com/trials/cognitive-training-to-improve-work-outcomes-in-severe-mental-illness-120501https://curecurrent.com/trials/efficacy-and-safety-study-of-a-combination-product-drug-bci-024-buspirone-and-drug-bci-049-melatonin-to-treat-major-depr-120502https://curecurrent.com/trials/a-multiple-ascending-oral-dose-evaluation-of-the-safety-tolerability-and-pharmacokinetics-of-dsp-1053-and-its-metabolite-120503https://curecurrent.com/trials/magnetic-seizure-therapy-mst-for-the-treatment-of-major-depression-120504https://curecurrent.com/trials/light-ion-and-fluoxetine-efficacy-life-in-depression-120505https://curecurrent.com/trials/cid-0911-adaptation-of-a-depression-treatment-intervention-for-hiv-patients-in-cameroon-120506https://curecurrent.com/trials/deplin-p-l-u-s-program-progress-through-learning-understanding-support-120507https://curecurrent.com/trials/mindfulness-based-cognitive-therapy-for-perinatal-women-with-mood-disorders-120508https://curecurrent.com/trials/safety-and-tolerability-of-vortioxetine-luaa21004-open-label-extension-study-120509https://curecurrent.com/trials/yoga-for-persons-with-severe-visual-impairment-120510https://curecurrent.com/trials/continuation-ketamine-in-major-depression-120511https://curecurrent.com/trials/aripiprazole-for-the-augmentation-of-antidepressant-therapy-120512https://curecurrent.com/trials/combining-antidepressant-medication-and-psychotherapy-for-insomnia-to-improve-depression-outcome-120513https://curecurrent.com/trials/pilot-study-in-multi-coil-repetitive-transcranial-magnetic-stimulation-rtms-for-treatment-resistant-depression-120514https://curecurrent.com/trials/mindfulness-based-cognitive-therapy-for-chronic-depression-120515https://curecurrent.com/trials/randomised-placebo-controlled-venlafaxine-referenced-study-of-efficacy-and-safety-of-5-and-10-mg-of-vortioxetine-lu-aa21-120516https://curecurrent.com/trials/star-d-alcohol-treatment-of-depression-concurrent-with-alcohol-abuse-120517https://curecurrent.com/trials/motivational-interviewing-to-improve-medication-adherence-among-hispanic-adults-with-depression-120518https://curecurrent.com/trials/agomelatine-in-depressed-patients-with-fibromyalgia-120519https://curecurrent.com/trials/individually-based-psychosocial-rehabilitation-for-older-people-with-serious-mental-illness-smi-120520https://curecurrent.com/trials/serotonin-transporter-genetic-variation-and-amygdala-responses-to-antidepressant-medications-in-major-depression-120521https://curecurrent.com/trials/effectiveness-of-rtms-with-double-cone-coil-in-patients-with-major-depression-120522https://curecurrent.com/trials/dopamine-neurotransmission-in-major-depression-120523https://curecurrent.com/trials/combining-medications-to-enhance-depression-outcomes-120524https://curecurrent.com/trials/a-working-memory-training-to-decrease-rumination-in-depressed-and-anxious-individuals-120525https://curecurrent.com/trials/tackling-depression-and-anxiety-a-working-memory-intervention-120526https://curecurrent.com/trials/understanding-brain-reward-responses-in-individuals-with-major-depressive-disorder-120527https://curecurrent.com/trials/treatment-for-adolescents-with-depression-study-tads-120528https://curecurrent.com/trials/do-antidepressants-induce-metabolic-syndromes-metadap-study-120529https://curecurrent.com/trials/a-study-to-assess-the-long-term-safety-of-tc-5214-as-an-adjunct-therapy-in-patients-with-major-depressive-disorder-120530https://curecurrent.com/trials/a-study-to-assess-the-efficacy-and-safety-of-tc-5214-as-an-adjunct-therapy-in-patients-with-major-depressive-disorder-120531https://curecurrent.com/trials/a-study-to-assess-the-efficacy-and-safety-of-tc-5214-as-an-adjunct-therapy-in-patients-with-major-depressive-disorder-md-120532https://curecurrent.com/trials/a-study-to-assess-the-efficacy-and-safety-of-tc-5214-as-an-adjunct-therapy-in-patients-with-major-depressive-disorder-120533https://curecurrent.com/trials/a-study-to-assess-the-efficacy-and-safety-of-tc-5214-as-an-adjunct-therapy-in-patients-with-major-depressive-disorder-120534https://curecurrent.com/trials/neuroimaging-study-of-bupropion-treatment-in-patients-with-major-depressive-disorder-120535https://curecurrent.com/trials/treatment-of-major-depression-with-st-john-s-wort-hypericum-120536https://curecurrent.com/trials/safety-efficacy-and-tolerability-of-vilazodone-in-major-depressive-disorder-120537https://curecurrent.com/trials/open-label-safety-extension-study-of-2-5-5-and-10-mg-of-vortioxetine-lu-aa21004-in-long-term-treatment-of-major-depressi-120538https://curecurrent.com/trials/efficacy-of-vortioxetine-lu-aa21004-in-the-prevention-of-relapse-of-major-depressive-episodes-120539https://curecurrent.com/trials/exploratory-study-on-the-mood-and-cytokine-levels-in-female-healthy-participants-and-major-depressive-disorder-patients-120540https://curecurrent.com/trials/reducing-the-risk-of-developing-major-depression-in-adolescents-young-adults-with-minor-depression-depression-symptoms-120541https://curecurrent.com/trials/a-study-of-vortioxetine-lu-aa21004-in-comparison-to-agomelatine-in-adults-suffering-from-major-depression-with-inadequat-120542https://curecurrent.com/trials/effectiveness-of-a-technology-assisted-behavioral-intervention-in-assisting-people-with-major-depressive-disorder-120543https://curecurrent.com/trials/clinical-and-biological-characteristics-of-psychotic-depression-120544https://curecurrent.com/trials/safety-study-of-escitalopram-in-children-7-to-11-years-of-age-with-major-depressive-disorder-120545https://curecurrent.com/trials/open-label-safety-extension-study-of-15-and-20-mg-of-vortioxetine-lu-aa21004-in-long-term-treatment-of-major-depressive-120546https://curecurrent.com/trials/randomised-placebo-controlled-duloxetine-referenced-efficacy-and-safety-study-of-2-5-5-and-10-mg-of-vortioxetine-lu-aa21-120547https://curecurrent.com/trials/randomised-placebo-controlled-duloxetine-referenced-study-of-efficacy-and-safety-of-15-and-20-mg-of-vortioxetine-lu-aa21-120548https://curecurrent.com/trials/telephone-care-as-a-substitute-for-routine-psychiatric-medication-120549https://curecurrent.com/trials/long-term-administration-study-of-aripiprazole-as-an-adjunctive-therapy-in-patients-with-major-depressive-disorder-120550https://curecurrent.com/trials/study-of-aripiprazole-as-an-adjunctive-therapy-in-patients-with-major-depressive-disorder-120551https://curecurrent.com/trials/general-practice-research-database-seroquel-xr-safety-study-120552https://curecurrent.com/trials/study-of-adolescence-and-depression-120553https://curecurrent.com/trials/optimization-of-iv-ketamine-for-treatment-resistant-depression-120554https://curecurrent.com/trials/open-label-safety-extension-study-of-5-and-10-mg-of-vortioxetine-lu-aa21004-in-long-term-treatment-of-major-depressive-d-120555https://curecurrent.com/trials/an-open-prospective-trial-of-iv-ketamine-in-suicidal-adolescents-120556https://curecurrent.com/trials/randomised-placebo-controlled-duloxetine-referenced-study-of-efficacy-and-safety-of-5-mg-of-vortioxetine-lu-aa21004-in-a-120557https://curecurrent.com/trials/physician-survey-on-monitoring-of-patients-treated-with-quetiapine-120558https://curecurrent.com/trials/emr-data-to-assess-monitoring-of-patients-treated-with-quetiapine-120559https://curecurrent.com/trials/study-evaluating-desvenlafaxine-succinate-sustained-release-dvs-sr-in-adult-outpatients-with-major-depressive-disorder-m-120560https://curecurrent.com/trials/phase-iv-safety-and-efficacy-of-emsam-in-adolescents-with-major-depression-120561https://curecurrent.com/trials/partner-assisted-interpersonal-psychotherapy-or-antidepressant-medication-for-antenatal-depression-120562https://curecurrent.com/trials/imaging-predictors-of-treatment-response-in-depression-120563https://curecurrent.com/trials/the-quietude-study-quetiapine-use-for-agitated-depression-120564https://curecurrent.com/trials/determining-optimal-continuation-treatment-duration-for-depressed-children-and-adolescents-120565https://curecurrent.com/trials/a-safety-and-efficacy-study-of-escitalopram-on-acute-treatment-of-severe-depression-120566https://curecurrent.com/trials/comparison-of-two-psychotherapy-treatments-for-depressed-women-with-a-history-of-sexual-abuse-120567https://curecurrent.com/trials/serum-markers-as-a-bioassay-for-unipolar-depression-120568https://curecurrent.com/trials/modulation-of-cognitive-control-by-transcranial-direct-current-stimulation-120569https://curecurrent.com/trials/exercise-and-severe-depression-clinical-and-biological-analysis-120570https://curecurrent.com/trials/combination-deplin-and-antidepressant-therapy-for-a-major-depressive-episode-mde-a-retrospective-analysis-120571https://curecurrent.com/trials/cardiovascular-effects-of-agomelatine-and-escitalopram-in-patients-with-major-depressive-disorder-mdd-120572https://curecurrent.com/trials/safety-and-efficacy-study-of-vortioxetine-lu-aa21004-in-adults-with-major-depressive-disorder-120573https://curecurrent.com/trials/efficacy-study-of-vortioxetine-lu-aa21004-in-adults-with-major-depressive-disorder-120574https://curecurrent.com/trials/efficacy-and-safety-study-of-vortioxetine-lu-aa21004-in-adults-with-major-depressive-disorder-120575https://curecurrent.com/trials/safety-and-efficacy-of-vortioxetine-lu-aa21004-in-adults-with-major-depressive-disorder-120576https://curecurrent.com/trials/efficacy-and-safety-study-of-vortioxetine-lu-aa21004-for-treatment-of-major-depressive-disorder-120577https://curecurrent.com/trials/efficacy-and-safety-of-vortioxetine-lu-aa21004-in-the-treatment-of-patients-with-major-depressive-disorder-120578https://curecurrent.com/trials/open-label-extension-assessing-the-tolerability-of-bci-024-in-combination-with-bci-049-in-patients-with-major-depressive-120579https://curecurrent.com/trials/antidepressant-monotherapy-on-depressive-and-anxiety-symptom-in-chinese-patients-120580https://curecurrent.com/trials/comparison-of-two-tdcs-protocols-for-the-treatment-of-major-depressive-disorder-120581https://curecurrent.com/trials/acupuncture-for-persistent-insomnia-associated-with-major-depressive-disorder-120582https://curecurrent.com/trials/safety-and-tolerability-of-vortioxetine-lu-aa21004-in-adults-with-major-depressive-disorder-120583https://curecurrent.com/trials/efficacy-and-safety-of-vortioxetine-lu-aa21004-in-treating-adults-with-major-depressive-disorder-120584https://curecurrent.com/trials/culturally-sensitive-collaborative-treatment-for-depressed-chinese-americans-120585https://curecurrent.com/trials/a-study-of-aripiprazole-in-patients-with-major-depressive-disorder-120586https://curecurrent.com/trials/electrophysiologic-parameters-and-biomarkers-predicting-treatment-response-in-patients-with-major-depressive-disorder-120587https://curecurrent.com/trials/a-study-of-adjunctive-aripiprazole-in-patients-with-major-depressive-disorder-120588https://curecurrent.com/trials/efficacy-study-of-rx-10100-to-treat-major-depressive-disorder-mdd-120589https://curecurrent.com/trials/treatment-of-reduced-heart-rate-variability-associated-with-major-depression-with-electroconvulsive-therapy-120590https://curecurrent.com/trials/safety-and-efficacy-of-rx-10100-to-treat-major-depressive-disorder-120591https://curecurrent.com/trials/cognitive-deficits-in-major-depressive-disorder-and-bipolar-disorder-depressed-type-prevalence-and-improvement-with-trea-120592https://curecurrent.com/trials/characterizing-psychological-consequences-of-childhood-trauma-120593https://curecurrent.com/trials/cimicoxib-for-the-treatment-of-major-depression-secim-120594https://curecurrent.com/trials/a-study-of-aripiprazole-in-patients-with-bipolar-i-disorder-with-a-major-depressive-episode-120595https://curecurrent.com/trials/study-of-aripiprazole-in-patients-with-bipolar-i-disorder-with-a-major-depression-episode-120596https://curecurrent.com/trials/provigil-in-conjunction-with-ssris-for-the-treatment-of-mild-or-moderate-depression-with-attendant-symptoms-of-sleepines-120597https://curecurrent.com/trials/does-fluoxetine-have-an-effect-on-the-cns-crf-systems-in-women-abused-in-childhood-120598https://curecurrent.com/trials/a-long-term-study-of-aripiprazole-in-patients-with-major-depressive-disorder-120599https://curecurrent.com/trials/outcomes-in-measurement-based-treatment-120600https://curecurrent.com/trials/the-effect-of-patient-cost-sharing-on-antidepressant-and-adjunctive-therapy-use-120601https://curecurrent.com/trials/retrospective-database-study-of-real-world-abilify-outcomes-in-major-depressive-disorder-mdd-120602https://curecurrent.com/trials/a-study-of-aripiprazole-in-patients-with-bipolar-i-disorder-with-a-major-depressive-episode-120603https://curecurrent.com/trials/impact-of-atypical-antipsychotic-therapy-on-health-outcomes-and-costs-among-patients-with-major-depressive-disorder-120604https://curecurrent.com/trials/a-study-of-sustained-release-desvenlafaxine-hydrochloride-for-the-treatment-of-major-depressive-disorder-120605https://curecurrent.com/trials/long-term-extension-study-of-lu-aa21004-in-participants-with-major-depressive-disorder-120606https://curecurrent.com/trials/treatment-choices-for-improving-adherence-and-outcome-120607https://curecurrent.com/trials/paroxetine-referenced-study-evaluating-three-doses-of-dvs-sr-in-outpatients-with-mdd-120608https://curecurrent.com/trials/safety-and-efficacy-of-levomilnacipran-er-levomilnacipran-sr-in-major-depressive-disorder-120609https://curecurrent.com/trials/n-3-polyunsaturated-fatty-acids-in-the-prevention-and-treatment-for-ifn-induced-depression-120610https://curecurrent.com/trials/safety-and-efficacy-of-levomilnacipran-er-f2695-sr-in-major-depressive-disorder-120611https://curecurrent.com/trials/safety-and-efficacy-of-levomilnacipran-er-f2695-sr-in-major-depressive-disorder-120612https://curecurrent.com/trials/safety-and-efficacy-of-levomilnacipran-er-f2695-sr-in-major-depressive-disorder-120613https://curecurrent.com/trials/life-improvement-following-traumatic-brain-injury-120614https://curecurrent.com/trials/effectiveness-of-theta-burst-stimulation-tbs-in-patients-with-major-depression-120615https://curecurrent.com/trials/testing-the-effectiveness-of-a-computer-based-program-for-depression-120616https://curecurrent.com/trials/efficacy-and-safety-study-of-abt-436-in-major-depressive-disorder-120617https://curecurrent.com/trials/study-of-a-repetitive-transcranial-magnetic-stimulation-rtms-device-for-the-treatment-of-major-depressive-disorder-120618https://curecurrent.com/trials/investigating-the-effectiveness-of-telepsychiatry-for-treating-major-depression-in-a-chinese-american-nursing-home-120619https://curecurrent.com/trials/health-care-management-and-rehabilitation-skills-training-for-treating-serious-mental-illness-in-older-people-120620https://curecurrent.com/trials/cognitive-training-for-depression-120621https://curecurrent.com/trials/treatment-for-chronic-depression-120622https://curecurrent.com/trials/major-depressive-disorder-in-the-elderly-120623https://curecurrent.com/trials/use-of-ketamine-to-enhance-electroconvulsive-therapy-ect-in-depression-120624https://curecurrent.com/trials/presence-project-an-early-palliative-care-intervention-in-brain-tumors-120625https://curecurrent.com/trials/thinking-skills-for-work-in-severe-mental-illness-120626https://curecurrent.com/trials/mbcgt-and-psycho-physiological-stress-regulation-group-for-depression-and-psycho-physiological-stress-patient-120627https://curecurrent.com/trials/assessment-of-cognitive-functioning-before-and-after-treatment-with-duloxetine-120628https://curecurrent.com/trials/functional-and-neurochemical-correlates-of-treatment-response-in-major-depressive-disorder-120629https://curecurrent.com/trials/study-of-probiotic-ganedenbc30-for-irritable-bowel-syndrome-and-major-depressive-disorder-120630https://curecurrent.com/trials/childhood-adversity-genetic-polymorphisms-and-stress-in-first-onset-major-depression-120631https://curecurrent.com/trials/a-pilot-study-of-citicoline-add-on-therapy-in-patients-with-bipolar-disorder-or-major-depressive-disorder-and-amphetamin-120632https://curecurrent.com/trials/study-of-pharmacotherapy-of-psychotic-depression-120633https://curecurrent.com/trials/the-effects-of-sleep-deprivation-on-antidepressant-response-120634https://curecurrent.com/trials/pilot-study-of-duloxetine-in-psychological-resilience-120635https://curecurrent.com/trials/sleep-deprivation-plus-paroxetine-for-treating-major-depression-in-elderly-individuals-120636https://curecurrent.com/trials/paroxetine-and-interpersonal-psychotherapy-for-maintaining-health-and-well-being-in-elderly-individuals-with-depression-120637https://curecurrent.com/trials/late-life-depression-and-cerebral-perfusion-120638https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-and-venlafaxine-in-depression-120639https://curecurrent.com/trials/efficacy-and-safety-of-armodafinil-for-adults-with-excessive-sleepiness-obstructive-sleep-apnea-hypopnea-and-depression-120640https://curecurrent.com/trials/armodafinil-treatment-as-adjunctive-therapy-in-adults-with-major-depression-associated-with-bipolar-i-disorder-120641https://curecurrent.com/trials/pharmacological-intervention-project-fluoxetine-120642https://curecurrent.com/trials/effectiveness-of-telephone-versus-face-to-face-cbt-in-treating-people-with-depression-120643https://curecurrent.com/trials/long-term-bilateral-theta-burst-stimulation-for-the-treatment-of-major-depression-120644https://curecurrent.com/trials/cognitive-behavioral-therapy-for-the-treatment-of-depression-related-insomnia-120645https://curecurrent.com/trials/motivationally-enhanced-brief-interpersonal-psychotherapy-for-depressed-mothers-of-ill-children-120646https://curecurrent.com/trials/comparing-various-treatments-for-achieving-and-maintaining-remission-of-depression-120647https://curecurrent.com/trials/effectiveness-of-fluoxetine-in-young-people-for-the-treatment-of-major-depression-and-marijuana-dependence-120648https://curecurrent.com/trials/treatment-of-mood-and-marriage-study-tomms-120649https://curecurrent.com/trials/tc-5214-as-add-on-the-treatment-of-major-depressive-disorder-120650https://curecurrent.com/trials/open-label-study-of-geodon-in-non-rapid-cycling-bipolar-ii-patients-with-major-depression-120651https://curecurrent.com/trials/effects-of-sevoflurane-and-ketamine-on-qt-in-electroconvulsive-therapy-120652https://curecurrent.com/trials/behavioral-insomnia-therapy-for-those-with-insomnia-and-depression-120653https://curecurrent.com/trials/escitalopram-lexapro-in-patients-with-major-depression-with-atypical-features-120654https://curecurrent.com/trials/transcranial-magnetic-stimulation-for-treating-women-with-chronic-widespread-pain-120655https://curecurrent.com/trials/treating-depression-with-transcranial-direct-current-stimulation-tdcs-120656https://curecurrent.com/trials/neural-correlates-of-psychodynamic-psychotherapy-for-depression-120657https://curecurrent.com/trials/cognitive-behavioral-therapy-and-interpersonal-psychotherapy-as-treatment-for-major-depressive-disorder-120658https://curecurrent.com/trials/mindfulness-based-cognitive-therapy-for-chronic-pain-and-comorbid-unipolar-depression-120659https://curecurrent.com/trials/group-intervention-for-interpersonal-trauma-120660https://curecurrent.com/trials/biomarkers-for-outcomes-in-late-life-depression-bold-120661https://curecurrent.com/trials/creatine-as-a-new-therapeutic-strategy-in-depression-120662https://curecurrent.com/trials/a-clinical-trial-to-evaluate-the-efficacy-and-safety-of-generic-escitalopram-in-depression-120663https://curecurrent.com/trials/rtms-for-adolescents-and-young-adults-120664https://curecurrent.com/trials/decreasing-the-use-of-unmodified-electroconvulsive-therapy-ect-in-an-indian-hospital-120665https://curecurrent.com/trials/omega-3-fatty-acids-for-treating-adults-with-major-depression-120666https://curecurrent.com/trials/dental-status-of-patients-with-severe-mental-illness-120667https://curecurrent.com/trials/effectiveness-of-parent-child-interaction-and-emotion-development-therapy-in-treating-preschool-children-with-depression-120668https://curecurrent.com/trials/augmentation-of-the-antidepressant-action-of-sertraline-with-triiodothyronine-t3-and-reboxetine-clinical-efficacy-advers-120669https://curecurrent.com/trials/an-eight-week-study-of-ssr411298-as-treatment-for-major-depressive-disorder-in-elderly-patients-120670https://curecurrent.com/trials/depression-outcomes-study-of-exercise-120671https://curecurrent.com/trials/environmental-treatment-for-seasonal-affective-disorder-sad-120672https://curecurrent.com/trials/ultrabrief-pulsewidth-electroconvulsive-therapy-ect-120673https://curecurrent.com/trials/second-generation-antipsychotic-treatment-indication-effectiveness-and-tolerability-in-youth-satiety-study-120674https://curecurrent.com/trials/the-metabolic-effects-of-antidepressants-in-patients-diagnosed-with-major-depressive-disorder-120675https://curecurrent.com/trials/a-study-for-assessing-treatment-of-patients-ages-10-17-with-bipolar-depression-120676https://curecurrent.com/trials/quetiapine-prolong-escitalopram-and-hypothalamic-pituitary-adrenocortical-hpa-axis-activity-in-depressed-patients-120677https://curecurrent.com/trials/study-evaluating-the-pharmacokinetics-of-venlafaxine-er-and-desvenlafaxine-sr-in-healthy-subjects-120678https://curecurrent.com/trials/adapting-cognitive-behavioral-therapy-cbt-for-chinese-americans-120679https://curecurrent.com/trials/a-neuroimaging-investigation-of-brain-activity-in-major-depressive-disorder-and-bipolar-disorder-120680https://curecurrent.com/trials/efficacy-and-safety-curcumin-in-depression-120681https://curecurrent.com/trials/neurophysiologic-predictors-of-outcome-with-rtms-treatment-of-major-depressive-disorder-120682https://curecurrent.com/trials/personalized-indicators-for-predicting-response-to-ssri-treatment-in-major-depression-the-prise-md-study-120683https://curecurrent.com/trials/trigeminal-nerve-stimulation-for-post-traumatic-stress-disorder-ptsd-and-depression-120684https://curecurrent.com/trials/adjunctive-transcranial-direct-current-stimulation-for-cognition-in-major-depression-120685https://curecurrent.com/trials/trigeminal-nerve-stimulation-for-depression-dose-finding-120686https://curecurrent.com/trials/lexapro-and-pramipexole-and-to-treat-major-depression-120687https://curecurrent.com/trials/comparison-of-tianeptine-versus-escitalopram-patients-major-depressive-disorder-120688https://curecurrent.com/trials/cortical-gaba-concentrations-in-insomnia-120689https://curecurrent.com/trials/effectiveness-of-deep-transcranial-magnetic-stimulation-in-depression-120690https://curecurrent.com/trials/pilot-study-of-open-label-placebo-to-treat-major-depressive-disorder-120691https://curecurrent.com/trials/study-of-cerebral-function-in-patients-with-chronic-hepatitis-c-infection-hcv-cns-120692https://curecurrent.com/trials/algorithm-guided-treatment-strategies-for-major-depressive-disorder-120693https://curecurrent.com/trials/short-term-study-of-combination-treatment-of-escitalopram-and-gaboxadol-in-major-depressive-disorder-120694https://curecurrent.com/trials/major-depressive-disorder-with-mixed-features-120695https://curecurrent.com/trials/determining-highest-dose-administration-of-tc-5214-and-evaluating-effect-on-the-electrical-activity-in-the-heart-120696https://curecurrent.com/trials/randomized-placebo-controlled-trial-of-an-ampakine-in-major-depressive-disorder-120697https://curecurrent.com/trials/yoga-in-unipolar-and-bipolar-disorders-120698https://curecurrent.com/trials/the-use-of-galantamine-hbr-reminyl-in-electroconvulsive-therapy-impact-on-mood-and-cognitive-functioning-120699https://curecurrent.com/trials/effects-of-testosterone-in-women-with-depression-120700https://curecurrent.com/trials/associations-between-depression-and-cardiovascular-disease-a-study-of-patients-with-late-onset-depression-120701https://curecurrent.com/trials/a-study-to-assess-the-safety-and-effect-of-tc-5214-in-patients-with-major-depressive-disorder-120702https://curecurrent.com/trials/study-of-antidepressant-efficacy-of-a-selective-high-affinity-enkephalinergic-agonist-in-anxious-major-depressive-disord-120703https://curecurrent.com/trials/the-effect-of-quetiapine-xr-in-depressive-patients-showing-aberrant-n100-amplitude-slope-120704https://curecurrent.com/trials/randomized-clinical-trial-of-an-exposure-based-cognitive-therapy-for-depression-120705https://curecurrent.com/trials/aripiprazole-augmentation-of-ssri-therapy-in-treatment-refractory-depression-120706https://curecurrent.com/trials/effectiveness-of-culturally-based-congruent-care-in-treating-hispanics-with-major-depressive-disorder-120707https://curecurrent.com/trials/risperidone-vs-paroxetine-for-panic-attacks-120708https://curecurrent.com/trials/effectiveness-of-buddhist-monks-in-providing-cognitive-behavior-therapy-120709https://curecurrent.com/trials/brain-imaging-of-psychotherapy-for-depression-120710https://curecurrent.com/trials/6-week-study-treatment-to-evaluate-the-safety-and-effectiveness-of-azd2066-in-patients-with-major-depressive-disorder-120711https://curecurrent.com/trials/eszopiclone-co-administered-with-escitalopram-for-insomnia-in-elderly-adults-with-major-depressive-disorder-120712https://curecurrent.com/trials/cognitive-control-training-as-an-adjunct-to-behavioral-activation-therapy-in-the-treatment-of-depression-120713https://curecurrent.com/trials/effects-of-repeated-attachment-security-priming-on-depressed-mood-a-clinical-study-120714https://curecurrent.com/trials/study-assessing-the-safety-and-therapeutic-effect-of-buprenorphine-in-mdd-patients-120715https://curecurrent.com/trials/study-of-mindfulness-based-cognitive-therapy-120716https://curecurrent.com/trials/cognitive-bias-modification-cbm-and-internet-cognitive-behavioural-therapy-icbt-for-depression-a-randomised-controlled-t-120717https://curecurrent.com/trials/single-iv-dose-of-glyx-13-in-patients-with-treatment-resistant-depression-120718https://curecurrent.com/trials/incidence-of-metabolic-syndrome-and-thyroid-dysfunction-in-patients-with-major-depressive-disorder-120719https://curecurrent.com/trials/the-study-of-antidepressant-properties-and-safety-of-fer-01-soline-on-the-patients-with-depression-120720https://curecurrent.com/trials/study-comparing-remission-rates-in-patients-with-major-depressive-disorder-mdd-120721https://curecurrent.com/trials/the-combination-of-aripiprazole-and-antidepressants-in-psychotic-major-depression-120722https://curecurrent.com/trials/safety-study-of-f2695-sr-in-major-depressive-disorder-120723https://curecurrent.com/trials/major-depressive-disorder-mdd-120724https://curecurrent.com/trials/cognitive-behavioral-treatment-for-post-traumatic-stress-disorder-in-people-with-additional-serious-mental-illnesses-120725https://curecurrent.com/trials/d-cycloserine-for-major-depressive-disorder-120726https://curecurrent.com/trials/antidepressant-effects-of-nr2b-in-major-depression-120727https://curecurrent.com/trials/assessment-of-pituitary-adenylate-cyclase-activating-polypeptide-brain-derived-neurotrophic-factor-pacap-bdnf-signaling-120728https://curecurrent.com/trials/azd6765-severe-major-depressive-disorder-mdd-iv-120729https://curecurrent.com/trials/inflammatory-markers-and-cognitive-function-in-major-depression-120730https://curecurrent.com/trials/org-24448-to-treat-major-depression-120731https://curecurrent.com/trials/efficacy-and-safety-of-homeopathy-for-moderate-depression-acute-phase-120732https://curecurrent.com/trials/duloxetine-for-perimenopausal-depression-120733https://curecurrent.com/trials/acamprosate-added-to-escitalopram-and-behavioral-treatment-for-comorbid-depression-and-alcoholism-120734https://curecurrent.com/trials/effectiveness-of-acupuncture-for-depressed-patients-not-taking-antidepressant-medications-120735https://curecurrent.com/trials/a-prospective-comparative-study-to-explore-the-efficacy-and-safety-of-the-five-channels-multiway-deep-transcranial-magne-120736https://curecurrent.com/trials/oral-tyramine-pressor-response-study-of-cx157-tablets-in-healthy-male-volunteers-120737https://curecurrent.com/trials/open-study-assessing-the-feasibility-of-minocycline-in-patients-with-unipolar-depression-120738https://curecurrent.com/trials/internet-intervention-for-the-prevention-of-depression-approaches-to-improving-mood-120739https://curecurrent.com/trials/a-study-of-cx157-tririma-for-the-treatment-of-depression-120740https://curecurrent.com/trials/description-of-treatment-management-of-patients-with-major-depressive-disorder-and-inadequate-response-120741https://curecurrent.com/trials/randomised-controlled-trial-of-electroconvulsive-therapy-ect-in-relapse-prevention-of-depression-120742https://curecurrent.com/trials/deep-brain-stimulation-for-treatment-refractory-major-depression-120743https://curecurrent.com/trials/the-effects-of-ropinirole-on-mood-or-mild-depression-in-patients-with-moderate-to-severe-restless-legs-syndrome-120744https://curecurrent.com/trials/a-local-register-study-for-major-depression-of-paroxetine-controlled-release-120745https://curecurrent.com/trials/evaluation-of-the-potential-effects-of-ssr149415-on-the-hypothalamic-pituitary-adrenal-axis-in-outpatients-with-major-de-120746https://curecurrent.com/trials/comparing-quetiapine-xr-monotherapy-and-augmentation-with-lithium-augmentation-in-trd-patients-120747https://curecurrent.com/trials/escitalopram-combination-comparison-study-for-adult-patients-with-major-depressive-disorder-120748https://curecurrent.com/trials/pioglitazone-as-an-adjunct-for-moderate-to-severe-depressive-disorder-120749https://curecurrent.com/trials/the-worker-study-escitalopram-and-telephone-based-cognitive-behaviour-therapy-cbt-for-depressed-working-people-120750https://curecurrent.com/trials/safety-and-efficacy-study-of-vilazodone-and-discovering-genetic-markers-associated-with-response-in-patients-with-major-120751https://curecurrent.com/trials/a-multiple-ascending-dose-study-of-bci-838-in-healthy-volunteers-120752https://curecurrent.com/trials/study-of-ketamine-as-an-antidepressant-in-major-depressive-disorder-120753https://curecurrent.com/trials/computerized-information-processing-bias-retraining-in-depressed-adolescents-120754https://curecurrent.com/trials/stress-reduction-intervention-for-enhancing-treatment-outcome-for-depressed-minority-patients-120755https://curecurrent.com/trials/a-randomized-double-blind-two-arm-study-comparing-the-efficacy-and-safety-of-trazodone-contramid-oad-and-placebo-in-the-120756https://curecurrent.com/trials/are-two-antidepressants-a-good-initial-treatment-for-depression-120757https://curecurrent.com/trials/treatment-of-depression-following-multiple-brain-tests-120758https://curecurrent.com/trials/sequential-tranylcypromine-tc-tc-dextroamphetamine-and-tc-triiodothyronine-for-refractory-depression-120759https://curecurrent.com/trials/effectiveness-of-pramipexole-for-treatment-resistant-depression-120760https://curecurrent.com/trials/expanding-and-testing-va-collaborative-care-models-for-depression-120761https://curecurrent.com/trials/open-label-randomized-study-evaluating-treatment-with-venlafaxine-extended-release-plus-dialogues-time-to-talk-program-120762https://curecurrent.com/trials/ecare-for-moods-an-internet-based-management-program-120763https://curecurrent.com/trials/a-study-in-the-treatment-of-children-and-adolescents-with-major-depressive-disorder-120764https://curecurrent.com/trials/genetic-study-of-liver-enzymes-in-patients-with-side-effects-from-antidepressants-120765https://curecurrent.com/trials/tai-chi-training-for-treating-depressed-chinese-americans-120766https://curecurrent.com/trials/azd7268-safety-and-tolerability-study-120767https://curecurrent.com/trials/the-efficacy-of-parent-involvement-in-the-treatment-of-adolescent-depression-120768https://curecurrent.com/trials/the-safety-and-efficacy-of-escitalopram-in-pediatric-patients-with-major-depressive-disorder-120769https://curecurrent.com/trials/study-evaluating-desvenlafaxine-succinate-sustained-release-dvs-sr-in-the-treatment-of-peri-and-postmenopausal-women-wit-120770https://curecurrent.com/trials/pregnenolone-trial-for-depression-in-bipolar-disorders-or-recurrent-major-depressive-disorder-with-substance-abuse-120771https://curecurrent.com/trials/omacor-for-perimenopausal-depression-120772https://curecurrent.com/trials/can-vitamin-d3-supplementation-affect-treatment-outcomes-in-patients-with-depression-120773https://curecurrent.com/trials/improving-depression-care-for-elders-coordinating-center-120774https://curecurrent.com/trials/safety-and-pharmacology-study-of-bms-866949-120775https://curecurrent.com/trials/follow-up-study-of-transcranial-direct-current-stimulation-to-treat-major-depressive-disorder-120776https://curecurrent.com/trials/antepartum-study-on-use-of-interpersonal-psychotherapy-at-3-new-york-city-site-120777https://curecurrent.com/trials/a-non-interventional-study-to-investigating-the-ratio-of-mis-diagnosed-bipolar-symptoms-in-patient-with-major-depressive-120778https://curecurrent.com/trials/patient-tolerability-study-of-gsk163090-120779https://curecurrent.com/trials/efficacy-study-of-botox-for-depression-120780https://curecurrent.com/trials/study-evaluating-desvenlafaxine-succinate-sustained-release-dvs-sr-in-the-treatment-of-major-depressive-disorder-120781https://curecurrent.com/trials/interpersonal-psychotherapy-for-depressed-adolescents-and-parents-120782https://curecurrent.com/trials/eeg-biomarkers-for-predicting-response-to-antidepressant-therapy-120783https://curecurrent.com/trials/a-study-of-bci-838-and-several-bci-632-prodrugs-in-healthy-volunteers-120784https://curecurrent.com/trials/study-of-escitalopram-in-adult-patients-with-major-depressive-disorder-120785https://curecurrent.com/trials/comparison-of-escitalopram-combination-in-adult-patients-with-major-depressive-disorder-120786https://curecurrent.com/trials/study-comparing-the-efficacy-of-venlafaxine-xr-vs-ssris-and-conventional-antidepressants-in-depressed-patients-120787https://curecurrent.com/trials/study-of-the-effectiveness-of-vestibular-stimulation-as-a-coadjuvant-treatment-in-major-depression-120788https://curecurrent.com/trials/study-comparing-discontinuation-symptoms-of-dvs-sr-in-subjects-with-major-depressive-disorder-mdd-120789https://curecurrent.com/trials/perinatal-depression-treatment-in-a-pediatric-setting-pilot-phase-120790https://curecurrent.com/trials/a-safety-efficacy-and-tolerability-study-of-sep-225289-120791https://curecurrent.com/trials/a-study-of-eszopiclone-in-subjects-with-insomnia-related-to-major-depressive-disorder-120792https://curecurrent.com/trials/a-study-of-eszopiclone-co-administered-with-venlafaxine-in-subjects-with-major-depressive-disorder-and-insomnia-120793https://curecurrent.com/trials/duke-conte-center-for-the-neuroscience-of-depression-in-late-life-120794https://curecurrent.com/trials/an-eight-week-study-to-evaluate-the-efficacy-and-safety-of-saredutant-in-patients-with-depression-120795https://curecurrent.com/trials/a-fifty-two-week-study-to-evaluate-the-safety-of-saredutant-in-adult-and-elderly-patients-with-depression-120796https://curecurrent.com/trials/a-united-states-study-of-the-safety-and-tolerability-of-corlux-for-psychotic-symptoms-in-psychotic-major-depression-120797https://curecurrent.com/trials/an-international-study-of-the-safety-and-tolerability-of-corlux-for-psychotic-symptoms-in-psychotic-major-depression-120798https://curecurrent.com/trials/a-united-states-extension-study-of-corlux-for-recurrent-psychotic-symptoms-in-psychotic-major-depression-120799https://curecurrent.com/trials/a-united-states-study-of-corlux-for-psychotic-symptoms-in-psychotic-major-depression-120800https://curecurrent.com/trials/an-international-extension-study-of-corlux-for-recurrent-psychotic-symptoms-in-psychotic-major-depression-120801https://curecurrent.com/trials/a-study-in-depression-and-associated-painful-physical-symptoms-120802https://curecurrent.com/trials/transcranial-direct-current-stimulation-tdcs-in-the-treatment-of-major-depressive-disorder-mdd-120803https://curecurrent.com/trials/longitudinal-study-of-people-presenting-for-first-treatment-of-a-mood-disorder-120804https://curecurrent.com/trials/desvenlafaxine-succinate-dvs-for-major-depressive-disorder-mdd-in-midlife-men-and-women-120805https://curecurrent.com/trials/duloxetine-for-major-depression-in-peri-postmenopausal-women-120806https://curecurrent.com/trials/quetiapine-extended-release-xr-for-the-treatment-of-menopausal-depression-120807https://curecurrent.com/trials/changes-of-functional-connectivity-after-rtms-in-depression-120808https://curecurrent.com/trials/evaluation-of-the-h-coil-transcranial-magnetic-stimulation-tms-device-safety-and-feasibility-study-for-treatment-of-majo-120809https://curecurrent.com/trials/phase-1-study-to-test-the-bioequivalence-between-two-25-mg-tablets-vs-one-50-mg-tablet-under-fast-fed-condition-and-eval-120810https://curecurrent.com/trials/effect-of-postoperative-girdle-following-abdominal-surgery-on-pulmonary-function-mobilisation-and-postoperative-pain-120811https://curecurrent.com/trials/treating-refractory-major-depressive-disorder-with-repetitive-transcranial-magnetic-stimulation-120812https://curecurrent.com/trials/changes-in-cerebral-glucose-metabolism-after-electroconvulsive-therapy-ect-120813https://curecurrent.com/trials/oxytocin-and-tibolone-adjuncts-in-treatment-resistant-depression-a-pilot-study-120814https://curecurrent.com/trials/a-study-of-duloxetine-in-major-depressive-disorder-mdd-and-associated-painful-symptoms-120815https://curecurrent.com/trials/badalona-major-depressive-disorder-database-study-120816https://curecurrent.com/trials/evaluation-of-the-h-coil-transcranial-magnetic-stimulation-tms-device-safety-and-feasibility-study-for-acute-and-mainten-120817https://curecurrent.com/trials/pharmacokinetics-and-safety-of-desvenlafaxine-in-korean-healthy-subjects-following-single-and-multiple-oral-doses-of-des-120818https://curecurrent.com/trials/group-interpersonal-psychotherapy-for-depressed-adolescents-in-school-based-clinics-120819https://curecurrent.com/trials/study-of-methylphenidate-as-add-on-therapy-in-depressed-cancer-patients-120820https://curecurrent.com/trials/effect-of-antidepressants-on-white-matter-structure-120821https://curecurrent.com/trials/prozac-treatment-of-major-depression-discontinuation-study-120822https://curecurrent.com/trials/a-study-of-patients-with-major-depressive-disorder-and-residual-apathy-120823https://curecurrent.com/trials/aripiprazole-augmentation-versus-switching-to-different-class-of-antidepressants-in-major-depressive-disorder-120824https://curecurrent.com/trials/transcranial-direct-current-stimulation-to-treat-major-depressive-disorder-120825https://curecurrent.com/trials/validation-of-the-spanish-version-of-the-clinically-useful-depression-outcome-scale-cudos-scale-120826https://curecurrent.com/trials/efficacy-study-of-transcranial-direct-current-stimulation-to-treat-major-depressive-disorder-120827https://curecurrent.com/trials/attachment-security-as-mediator-and-moderator-of-outcome-in-major-depression-120828https://curecurrent.com/trials/study-comparing-adjunctive-risperidone-versus-placebo-in-major-depressive-disorder-that-is-not-responding-to-standard-th-120829https://curecurrent.com/trials/electroencephalography-eeg-signal-processing-120830https://curecurrent.com/trials/interventional-study-of-wellbutrin-xl-in-major-depressive-disorder-with-atypical-features-120831https://curecurrent.com/trials/advanced-mri-in-major-depression-120832https://curecurrent.com/trials/effects-of-electroconvulsive-therapy-ect-on-serotonin-1a-receptor-binding-120833https://curecurrent.com/trials/randomized-double-blinding-controlled-study-on-jia-wei-xiao-yao-jiaonang-treating-mild-to-moderate-major-depressive-diso-120834https://curecurrent.com/trials/evaluation-of-three-continuation-therapies-after-ect-concerning-efficacy-and-cognition-in-severly-depressed-patients-120835https://curecurrent.com/trials/analisis-of-facors-involved-in-antidepressant-treatment-response-of-major-depressive-disorder-120836https://curecurrent.com/trials/open-label-study-of-duloxetine-in-the-treatment-of-children-and-adolescents-with-major-depressive-disorder-120837https://curecurrent.com/trials/safety-and-effectiveness-study-of-bci-540-versus-placebo-in-the-treatment-of-major-depressive-disorder-with-concomitant-120838https://curecurrent.com/trials/vagus-nerve-stimulation-for-treating-adults-with-severe-fibromyalgia-120839https://curecurrent.com/trials/deep-brain-stimulation-in-treatment-resistant-depression-120840https://curecurrent.com/trials/beyond-ageing-project-a-study-for-the-prevention-of-depression-120841https://curecurrent.com/trials/pharmo-institute-seroquel-safety-study-120842https://curecurrent.com/trials/hormonal-levels-in-men-with-major-depressive-disorder-120843https://curecurrent.com/trials/safety-and-efficacy-study-of-citalopram-and-lithium-for-the-treatment-of-depressive-mood-disorder-symptoms-120844https://curecurrent.com/trials/alk33bup-201-safety-and-tolerability-study-of-alks-33-bup-alks-5461-administration-in-subjects-with-mdd-120845https://curecurrent.com/trials/study-evaluating-the-effect-of-desvenlafaxine-on-the-pharmacokinetics-of-midazolam-120846https://curecurrent.com/trials/prevention-of-depression-in-hiv-hcv-co-infected-substance-abuse-patients-120847https://curecurrent.com/trials/cognitive-behavioral-therapy-for-early-onset-depression-120848https://curecurrent.com/trials/transcranial-magnetic-treatment-tms-in-unipolar-depression-120849https://curecurrent.com/trials/identifying-very-early-response-to-seroquel-extended-release-xr-augmentation-for-major-depressive-disorder-120850https://curecurrent.com/trials/a-study-evaluating-duloxetine-in-patients-hospitalized-for-severe-depression-120851https://curecurrent.com/trials/escitalopram-treatment-of-major-depression-in-patients-with-temporal-lobe-epilepsy-120852https://curecurrent.com/trials/bupropion-sr-for-major-depression-and-depression-nos-in-children-and-adolescents-with-bipolar-disorder-120853https://curecurrent.com/trials/n-methylglycine-sarcosine-treatment-for-depression-120854https://curecurrent.com/trials/randomized-trial-of-psychotherapy-for-persistently-depressed-primary-care-patients-120855https://curecurrent.com/trials/a-study-of-quetiapine-fumarate-sustained-release-in-major-depression-with-comorbid-fibromyalgia-syndrome-120856https://curecurrent.com/trials/the-purpose-of-the-study-is-to-gain-an-in-depth-picture-of-the-patient-management-and-prescription-behaviours-120857https://curecurrent.com/trials/mothers-with-a-history-of-depression-and-their-10-14-year-old-daughters-120858https://curecurrent.com/trials/investigation-of-a-combination-treatment-of-escitalopram-and-rtms-120859https://curecurrent.com/trials/early-versus-delayed-switch-in-medication-in-patients-with-major-depressive-disorder-120860https://curecurrent.com/trials/study-of-the-changes-in-metabolic-parameters-in-patients-treated-with-escitalopram-for-six-months-120861https://curecurrent.com/trials/study-evaluating-desvenlafaxine-succinate-sustained-release-dvs-sr-in-the-treatment-of-major-depressive-disorder-120862https://curecurrent.com/trials/mindfulness-based-behavioural-therapy-mibt-versus-psychodynamic-therapy-for-patients-with-major-depressive-disorder-in-p-120863https://curecurrent.com/trials/ketamine-frequency-treatment-for-major-depressive-disorder-120864https://curecurrent.com/trials/neurophysiologic-monitoring-of-antidepressant-treatment-120865https://curecurrent.com/trials/the-study-of-serum-melatonin-rhythm-levels-in-patients-with-major-depressive-disorder-120866https://curecurrent.com/trials/a-study-of-the-effectiveness-and-safety-of-risperidone-to-augment-ssri-therapy-in-patients-with-treatment-resistant-depr-120867https://curecurrent.com/trials/concerta-methylphenidate-hydrochloride-as-add-on-therapy-in-the-treatment-of-adult-major-depressive-disorder-120868https://curecurrent.com/trials/study-evaluating-desvenlafaxine-succinate-sustained-release-in-adults-with-major-depressive-disorder-120869https://curecurrent.com/trials/pipamperone-citalopram-pipcit-versus-citalopram-in-the-treatment-of-major-depressive-disorder-mdd-120870https://curecurrent.com/trials/a-study-of-transcranial-direct-current-stimulation-tdcs-to-treat-depression-120871https://curecurrent.com/trials/long-term-safety-of-dvs-233-sr-in-patients-with-major-depressive-disorder-120872https://curecurrent.com/trials/effect-of-quetiapine-xr-on-sleep-in-patients-with-major-depression-as-compared-with-mirtazapine-120873https://curecurrent.com/trials/a-trial-evaluating-the-efficacy-and-tolerability-of-ssr125543-in-outpatients-with-major-depressive-disorder-120874https://curecurrent.com/trials/effects-of-antidepressants-on-sexual-functioning-in-adults-120875https://curecurrent.com/trials/measuring-response-to-depression-treatment-120876https://curecurrent.com/trials/study-evaluating-desvenlafaxine-succinate-sustained-release-in-outpatients-with-major-depressive-disorder-120877https://curecurrent.com/trials/bilateral-versus-monolateral-repetitive-transcranial-stimulation-in-depression-120878https://curecurrent.com/trials/study-evaluating-desvenlafaxine-succinate-sustained-release-dvs-sr-in-the-treatment-of-child-and-adolescent-outpatients-120879https://curecurrent.com/trials/retrospective-study-evaluating-the-current-utilization-of-desvenlafaxine-succinate-sustained-release-pristiq-among-psych-120880https://curecurrent.com/trials/efficacy-of-seroquel-sr-in-combination-with-an-antidepressant-in-treatment-of-major-depressive-disorder-120881https://curecurrent.com/trials/risperidone-vs-olanzapine-as-add-on-treatment-in-treatment-resistant-depression-120882https://curecurrent.com/trials/azd6765-for-treatment-resistant-depression-120883https://curecurrent.com/trials/treatment-resistant-depression-hippocampus-atrophy-and-serotonin-genetic-polymorphism-120884https://curecurrent.com/trials/safety-and-antidepressant-effects-of-rellidep-in-major-depressive-disorder-120885https://curecurrent.com/trials/dbs-in-treatment-resistant-major-depression-120886https://curecurrent.com/trials/a-nis-evaluating-the-treatment-patterns-of-atypical-antipsychotics-in-patients-diagnosed-with-bipolar-i-or-ii-disorder-120887https://curecurrent.com/trials/a-single-blind-trial-of-risperidone-vs-paroxetine-for-treatment-of-panic-attacks-120888https://curecurrent.com/trials/androgel-in-men-with-major-depression-and-incomplete-response-to-antidepressant-treatment-120889https://curecurrent.com/trials/the-effects-of-quetiapine-xr-on-cognition-mood-and-anxiety-symptoms-in-ssri-resistant-unipolar-depression-120890https://curecurrent.com/trials/mindfulness-and-lifestyle-interventions-for-depression-and-anxiety-a-pilot-study-120891https://curecurrent.com/trials/randomized-double-blind-placebo-controlled-study-of-vilazodone-s-efficacy-safety-and-biomarkers-of-response-in-major-dep-120892https://curecurrent.com/trials/an-8-week-depression-study-in-adults-diagnosed-with-major-depressive-disorder-120893https://curecurrent.com/trials/effects-of-antidepressants-on-sexual-functioning-120894https://curecurrent.com/trials/efficacy-and-safety-of-lu-aa34893-in-patients-with-major-depressive-disorder-120895https://curecurrent.com/trials/a-study-comparing-the-efficacy-and-safety-of-duloxetine-and-placebo-for-the-treatment-of-depression-in-elderly-patients-120896https://curecurrent.com/trials/pharmacogenomics-studies-of-antidepressants-120897https://curecurrent.com/trials/transcranial-direct-current-stimulation-tdcs-augmentation-by-d-cycloserine-as-a-treatment-for-depression-120898https://curecurrent.com/trials/switching-to-duloxetine-in-patients-with-depression-120899https://curecurrent.com/trials/functional-neuroimaging-in-depression-120900https://curecurrent.com/trials/brain-mechanisms-and-targeting-insomnia-in-major-depression-120901https://curecurrent.com/trials/cognitive-behavioural-analysis-system-of-psychotherapy-cbasp-versus-escitalopram-in-chronic-depression-120902https://curecurrent.com/trials/a-study-comparing-duloxetine-to-other-antidepressants-in-the-treatment-of-severe-depression-120903https://curecurrent.com/trials/an-eight-week-study-to-evaluate-the-efficacy-and-safety-of-saredutant-in-patients-with-depression-120904https://curecurrent.com/trials/exploring-a-potential-blood-test-to-diagnose-major-depressive-disorder-120905https://curecurrent.com/trials/a-study-of-6-s-5-mthf-among-serotonin-reuptake-inhibitor-ssri-resistant-outpatients-with-major-depressive-disorder-mdd-120906https://curecurrent.com/trials/study-of-supplementation-of-antidepressants-with-fish-oil-to-improve-time-to-clinical-response-120907https://curecurrent.com/trials/comparison-of-vitamin-b12-supplementation-to-selective-serotonin-reuptake-inhibitor-ssri-versus-ssri-antidepressant-trea-120908https://curecurrent.com/trials/effect-of-escitalopram-vs-reboxetine-on-gastro-intestinal-sensitivity-of-patients-with-major-depressive-disorder-120909https://curecurrent.com/trials/escitalopram-in-adult-patients-with-major-depressive-disorder-120910https://curecurrent.com/trials/fluoxetine-versus-fluoxetine-plus-du125530-in-major-depressive-disorder-120911https://curecurrent.com/trials/efficacy-and-safety-study-of-seroquel-sr-in-the-treatment-of-major-depressive-disorder-120912https://curecurrent.com/trials/fluvoxamine-maleate-in-the-treatment-of-depression-depressive-state-a-post-marketing-clinical-study-in-children-and-adol-120913https://curecurrent.com/trials/study-of-bms-562086-in-the-treatment-of-outpatients-with-major-depressive-disorder-120914https://curecurrent.com/trials/altered-calcium-and-vitamin-d-in-pmdd-or-severe-pms-120915https://curecurrent.com/trials/early-prediction-of-fluoxetine-response-120916https://curecurrent.com/trials/a-naturalistic-study-of-the-efficacy-and-safety-of-escitalopram-in-treatment-resistant-depression-120917https://curecurrent.com/trials/neuropattern-assessment-of-a-translational-diagnostic-tool-for-depression-adjustment-and-somatoform-disorders-120918https://curecurrent.com/trials/clinical-pharmacogenomics-of-antidepressant-response-120919https://curecurrent.com/trials/effect-of-curcumin-as-nutraceutical-in-patients-of-depression-120920https://curecurrent.com/trials/acupuncture-for-residual-insomnia-associated-with-major-depressive-disorder-120921https://curecurrent.com/trials/efficacy-and-safety-of-escitalopram-doses-up-to-50mg-in-treatment-of-mdd-120922https://curecurrent.com/trials/electroacupuncture-for-major-depression-120923https://curecurrent.com/trials/light-therapy-for-depression-during-pregnancy-120924https://curecurrent.com/trials/assessment-of-the-safety-and-effectiveness-of-cortical-stimulation-in-subjects-with-major-depressive-disorder-120925https://curecurrent.com/trials/antidepressant-incomplete-response-depression-120926https://curecurrent.com/trials/a-study-comparing-duloxetine-and-placebo-in-assessing-energy-and-vitality-in-major-depressive-disorder-mdd-patients-120927https://curecurrent.com/trials/transcranial-direct-current-stimulation-tdcs-in-treatment-resistant-depression-120928https://curecurrent.com/trials/brain-abnormalities-in-late-onset-major-depression-120929https://curecurrent.com/trials/cognitive-flexibility-in-major-depression-in-the-course-of-pharmacological-and-psychotherapeutic-treatment-120930https://curecurrent.com/trials/virtual-reality-vr-therapy-for-post-traumatic-stress-disorder-ptsd-120931https://curecurrent.com/trials/evaluation-of-the-h-coil-transcranial-magnetic-stimulation-tms-device-augmentation-for-drug-resistant-depression-120932https://curecurrent.com/trials/benefits-of-switching-antidepressants-following-early-nonresponse-120933https://curecurrent.com/trials/sequenced-treatment-alternatives-to-relieve-depression-star-d-120934https://curecurrent.com/trials/treating-alcohol-use-in-older-adults-with-depression-120935https://curecurrent.com/trials/brief-behavioral-therapy-for-insomnia-bbt-i-for-depressed-outpatients-with-refractory-insomnia-120936https://curecurrent.com/trials/a-6-week-study-to-determine-the-effectiveness-of-r228060-in-adult-subjects-with-major-depressive-disorder-120937https://curecurrent.com/trials/photobiomodulation-to-alter-cerebral-blood-flow-and-to-affect-the-emotional-status-of-patients-with-major-depression-120938https://curecurrent.com/trials/study-evaluating-dvs-233-sr-and-venlafaxine-er-in-adult-outpatients-with-major-depressive-disorder-120939https://curecurrent.com/trials/study-evaluating-dvs-233-sr-in-adult-outpatients-with-major-depressive-disorder-120940https://curecurrent.com/trials/study-evaluating-dvs-233-sr-and-venlafaxine-er-in-adult-outpatients-with-major-depressive-disorder-120941https://curecurrent.com/trials/study-evaluating-dvs-233-sr-in-adult-outpatients-with-major-depressive-disorder-120942https://curecurrent.com/trials/study-evaluating-dvs-233-in-adult-outpatients-with-major-depressive-disorder-120943https://curecurrent.com/trials/study-evaluating-dvs-233-sr-in-adult-outpatients-with-major-depressive-disorder-120944https://curecurrent.com/trials/study-evaluating-dvs-233-sr-in-elderly-outpatients-with-major-depressive-disorder-120945https://curecurrent.com/trials/study-evaluating-dvs-233-sr-in-adult-outpatients-with-major-depressive-disorder-120946https://curecurrent.com/trials/study-evaluating-venlafaxine-er-in-recurrent-depression-120947https://curecurrent.com/trials/chronos-the-use-of-chronobiological-treatment-in-depression-120948https://curecurrent.com/trials/cardiovascular-effects-of-sporting-events-120949https://curecurrent.com/trials/duloxetine-versus-placebo-in-the-prevention-of-recurrence-of-major-depressive-disorder-120950https://curecurrent.com/trials/multi-country-observational-study-to-collect-the-frequency-of-sexual-dysfunction-with-antidepressant-treatment-either-wi-120951https://curecurrent.com/trials/citalopram-versus-citalopram-plus-pindolol-in-major-depressive-disorder-120952https://curecurrent.com/trials/outcome-following-antidepressant-treatment-on-possible-endo-phenotypes-for-major-depression-120953https://curecurrent.com/trials/pulsed-electro-magnetic-fields-pemf-treatment-in-patients-with-treatment-resistant-major-depression-in-ongoing-pharmacol-120954https://curecurrent.com/trials/lamotrigine-augmentation-in-resistant-depression-120955https://curecurrent.com/trials/an-eight-week-study-evaluating-the-efficacy-and-tolerability-of-two-doses-of-ssr149415-in-outpatients-with-major-depress-120956https://curecurrent.com/trials/effect-of-partial-sleep-deprivation-on-cognition-and-cytokines-in-individuals-with-major-depression-120957https://curecurrent.com/trials/compare-the-efficacy-and-tolerability-of-the-combination-of-aripiprazole-and-selective-serotonin-reuptake-inhibitors-ssr-120958https://curecurrent.com/trials/quetiapine-fumarate-as-monotherapy-in-the-maintenance-treatment-of-patients-with-major-depressive-disorder-120959https://curecurrent.com/trials/efficacy-and-safety-of-sr58611a-in-patients-with-major-depressive-disorder-sirius-120960https://curecurrent.com/trials/efficacy-and-safety-of-quetiapine-fumarate-sustained-release-seroquel-sr-in-combination-with-an-antidepressant-in-the-tr-120961https://curecurrent.com/trials/safety-efficacy-study-of-quetiapine-fumarate-seroquel-vs-placebo-and-active-control-in-major-depressive-disorder-120962https://curecurrent.com/trials/efficacy-and-safety-of-sr58611-compared-to-placebo-and-paroxetine-120963https://curecurrent.com/trials/efficacy-and-safety-of-one-single-dose-of-sr58611-compared-to-placebo-and-paroxetine-120964https://curecurrent.com/trials/efficacy-and-safety-of-sr58611a-co-administered-with-escitalopram-in-adults-with-major-depressive-disorder-120965https://curecurrent.com/trials/long-term-safety-and-tolerability-of-sr58611-in-patients-with-major-depressive-disorder-120966https://curecurrent.com/trials/safety-efficacy-study-of-quetiapine-fumarate-seroquel-vs-placebo-in-major-depressive-disorder-120967https://curecurrent.com/trials/efficacy-of-seroquel-in-selective-serotonin-reuptake-inhibitors-ssri-resistant-major-depressive-disorder-120968https://curecurrent.com/trials/efficacy-and-safety-of-quetiapine-fumarate-sustained-release-seroquel-sr-in-the-treatment-of-major-depressive-disorders-120969https://curecurrent.com/trials/effect-of-the-menstrual-cycle-on-the-symptoms-of-depression-and-treatment-response-120970https://curecurrent.com/trials/an-eight-week-study-to-evaluate-the-efficacy-and-safety-of-sr58611a-in-elderly-patients-with-depression-120971https://curecurrent.com/trials/efficacy-and-safety-of-sr58611a-in-patients-with-major-depressive-disorder-120972https://curecurrent.com/trials/a-study-of-sr58611a-in-the-prevention-of-depression-relapse-in-patients-with-major-depressive-disorder-120973https://curecurrent.com/trials/efficacy-and-safety-of-sr58611a-in-patients-with-major-depressive-disorder-120974https://curecurrent.com/trials/study-comparing-two-types-of-psychotherapy-for-treating-depression-and-substance-abuse-120975https://curecurrent.com/trials/deep-brain-stimulation-for-refractory-major-depression-120976https://curecurrent.com/trials/memory-functioning-and-antidepressant-treatment-120977https://curecurrent.com/trials/reliability-and-validity-of-the-mini-international-neuropsychiatric-interview-for-children-and-adolescents-mini-kid-120978https://curecurrent.com/trials/evaluation-of-deep-transcranial-magnetic-stimulation-tms-h-coil-in-the-treatment-of-major-depression-120979https://curecurrent.com/trials/an-eight-week-study-evaluating-the-efficacy-of-two-fixed-doses-250-mg-twice-daily-and-100-mg-twice-daily-of-ssr149415-in-120980https://curecurrent.com/trials/an-eight-week-study-to-evaluate-the-efficacy-and-safety-of-saredutant-in-patients-with-depression-120981https://curecurrent.com/trials/efficacy-of-seroquel-sr-in-combination-with-an-antidepressant-in-treatment-of-major-depressive-disorder-120982https://curecurrent.com/trials/neurotrophic-factors-and-depression-120983https://curecurrent.com/trials/sa4503-8-week-study-in-major-depressive-disorder-mdd-120984https://curecurrent.com/trials/efficacy-and-safety-of-dov-21-947-in-the-treatment-of-major-depressive-disorder-120985https://curecurrent.com/trials/the-effect-of-duloxetine-on-interoceptive-awareness-120986https://curecurrent.com/trials/lexapro-in-the-treatment-of-patients-with-postpartum-depression-120987https://curecurrent.com/trials/a-research-study-to-compare-the-treatments-of-a-combination-of-elzasonan-with-zoloft-to-zoloft-alone-or-placebo-in-peopl-120988https://curecurrent.com/trials/antidepressant-treatment-of-mexican-americans-ucla-pharmacogenetics-and-pharmacogenomics-research-group-120989https://curecurrent.com/trials/safety-and-efficacy-of-venlafaxine-xr-in-elderly-patients-with-major-depression-120990https://curecurrent.com/trials/electroencephalography-eeg-biomarkers-of-response-in-depression-120991https://curecurrent.com/trials/assessing-treatment-emergent-suicidal-ideation-in-patients-with-major-depression-120992https://curecurrent.com/trials/patient-dimensions-as-predictors-of-varied-treatment-responses-and-outcomes-in-patients-with-major-depression-120993https://curecurrent.com/trials/stress-generation-and-recurrent-depression-the-role-of-differential-treatment-response-120994https://curecurrent.com/trials/effects-of-risperidone-and-olanzapine-on-patients-with-schizophrenia-schizoaffective-disorder-major-depression-or-bipola-120995https://curecurrent.com/trials/study-for-evaluating-different-methods-of-measuring-depression-treatment-response-120996https://curecurrent.com/trials/light-therapy-for-elderly-depression-120997https://curecurrent.com/trials/ambien-cr-for-treatment-of-insomnia-associated-with-depression-when-used-concomitantly-with-lexapro-120998https://curecurrent.com/trials/fluoxetine-vs-brief-psychotherapy-for-major-depression-120999https://curecurrent.com/trials/zinc-supplementation-of-imipramine-therapy-121000https://curecurrent.com/trials/essential-fatty-acids-for-major-depression-121001https://curecurrent.com/trials/antidepressant-maintenance-in-traumatic-brain-injury-121002https://curecurrent.com/trials/treatment-of-mdes-during-the-course-of-psychotic-disorders-with-duloxetine-121003https://curecurrent.com/trials/quantitative-eeg-qeeg-as-a-predictor-of-treatment-outcome-in-depression-121004https://curecurrent.com/trials/the-neurobiology-of-depressive-illness-121005https://curecurrent.com/trials/st-john-s-wort-and-kava-in-the-treatment-of-major-depressive-disorder-with-comorbid-anxiety-121006